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ABSTRACT OF THE DISSERTATION
Development and Application of Mass Spectrometry-Based Protein
Footprinting in Structural Proteomics

by
Ming Cheng
Doctor of Philosophy in Chemistry
Washington University in St. Louis, 2019
Professor Michael L Gross, Chair

Integral mass spectrometry (MS) has emerged as an important tool for protein structural
characterization. It readouts are a broad range of structural information, including stoichiometry,
interactions, conformations and conformation change, and dynamics. Protein footprinting is a
pivotal component in the intergral MS toolkit.
My dissertation centers around the development and application of protein footprinting to
characterize protein structure. It is divided into seven chapters.
Chapter 1 serves as the introduction for integral mass spectrometry in structural proteomic.
In Chapter 2, we extended the fast-photochemical oxidation of proteins (FPOP) platform by
adding the trifluoromethyl radical (•CF3) as a new reagent. We discovered that •CF3 footprint
proteins in a complementary way as hydroxide radicals. The •CF3 radical has exceptional reactivity,
modifying 18 amino acids out of 20. Further studies demonstrate that it can report the
xv

conformational change between holo-myoglobin and apo-myoglobin and can define the topology
of the VKOR membrane protein. This work bridges trifluoromethylation chemistry in materials
and medicinal chemistry to that in structural biology.
In Chapter 3, collaborated with Dr. Mark Chance’s laboratory in Case Western Reserve
University (CWRU) to apply •CF3 chemistry on the synchrotron platform, which is the first
platform that uses •OH for protein footprinting. Synchrotron radiolysis generates •CF3 in water
media by ionizing water molecules to give •OH. The •CF3 shows complementary chemical
reactivity with canonical •OH labeling yet results in higher reactivity coverage. The •CF3 reagent
is the second footprinting reagent enabled by synchrotron since 1999. This work serves as a proofof-concept to demonstrate that synchrotron platform is adaptable to other novel chemistries that
can increase footprinting coverage. Further, taking advantage of X-ray irradiation, we achieved
direct protein trifluoromethylation in the absence of metal catalysis or peroxide for the first time,
with the synchrotron platform.
In Chapter 4, we devloped a laser-mediated radical method for integral membrane protein (IMP)
footprinting. Classical footprinting methods use hydrophilic reagents to label protein surfaces. IN
so doing, we generate structural information by measuring the solvent accessibility of the
backbone or side chains in aqueous media. Owing to the amphipathic nature of IMP, this new
approach exploits the highly hydrophobic nature of perfluoroalkyl iodine together with tip
sonication to ensure efficient labeling of a transmembrane domain (TM). The chemistry yields
100% reactivity coverage for tyrosine, and complete IMP labeling in a fast fashion. The resulting
protein modification, which is resistant to hydrolysis, compatible with proteolysis, and amenable

xvi

of tandem mass analysis, is appropriate for footprinting by bottom-up analysis. (Collaboration with
Dr. Weikai Li from Wash U Medical School)
In Chapter 5, we investigated an array of digestion conditions by using different combination of
protease and additives to optimize the coverage of IMP digestion. IMPs are under-represented in
conventional bottom-up proteomic analysis that generally favors soluble, abundant and easy-todigest proteins. The new protrocol of IMP digestion significantly decreases our workload for
sample preparation, allows us to avoid common contaminants that impair LC-MS, and generally
yields >90% sequence coverage by generating peptides suitable for structural proteomic studies.
Further, the deep analysis enable us to identify a “sweet spot” in the digestion protocol that may
provide guidance to choose a suitable protease in structural proteomics in future.
In Chapter 6, apart from methodology development, we used hydrogen/deuterium exchange mass
spectrometry (HDX-MS) to characterize the binding interface for Mxra8-immune complex and
Mxra8-chikungunya virus protein complex. The cell adhesion molecule Mxra8 is identified as a
receptor for multiple arthritogenic alphaviruses such as chikungunya virus. We identified putative
binding sites for eight anti-Mxra8 monoclonal antibodies (mAbs). HDX-MS enables us to classify
the novel mAbs, predict their competing binding interface with chikungunya virus, and provide a
molecular level explanation for the observation that mAbs can block the Chikungunya virus
infection. From the HDX kinetic curves, we also observe that the mAbs have higher affinity than
do Chikungunya virus proteins when binding with Mxa8. Finally, the HDX data help to assign the
orientation of Mxra8 on the Cryo-EM structure of Chikungunya virus complex (Collaboration
with Dr. Daved H. Fremont and Dr. Michael s Diamond, Wash U School of Medicine).

xvii

In Chapter 7, we provide a conclusion for my dissertation. We will discuss challenges and
opportunities for protein footprinting, and its role in the expanding toolkit of structural proteomics.
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Chapter I. Introduction of Mass
Spectrometry-based Techniques in
Structural Proteomics

This chapter is based on in part on a recent accepted mini review: Ming Cheng; Chunyang Guo
and Michael L Gross. The Application of Fluorine Containing Reagents in Structural Proteomics.
Angew. Chem. Int. Ed. 2019.
1

1.1. Abstract
The biological function for a protein is determined by their high-order structure, dynamics, and
their organization into assemblies such as protein complexes and regulatory networks. With the
rapid technological advancement in structural biology, specifically with recent breaktrough in
high-resolution cryo-electron microscopy (Cryo-EM) and with continuing developments in
crystallography, novel interfaces with other biophysical methods are emerging. In the past two
decades, mass spectrometry (MS) has been a key enabling technology for high-throughput and
comprehensive protein identification and quantification on a proteome-wide scale. More recently,
when combined with other techniques (e.g., native spray, ion-mobility spectrometry, protein
footprinting, and cross-linking), MS can also be used to study higher-order structures of
biomacromolecules in a variety of ways. We term this relatively new field as “structural
proteomics”.
There are a number of MS-based tools in structural proteomics. In one approach, intact proteins or
protein complexes can be directly probed in the gas phase of a mass spectrometer. Alternatively,
various forms of solution-phase chemistry (e.g., covalent labeling) have been developed to
introduce modifications in intact proteins and locate these modifications by MS analysis. This
approach can provide structural information at the peptide level or even the residue level. In this
chapter, we will put a spotlight on the central role of mass spectrometry-based methods that bridge
proteomics and structural biology. We will compare the advantages and disadvantages between
classical methods and MS-based methods. We will discuss current tools available in the structural
proteomic toolkit. Finally, we will introduce some method developments that sharpen the tools in
the MS-based toolkite. This work was recently accepted by Angew. Chem. Int. Ed.
10.1002/anie.201907662.
2

1.2. Classical structural methods
Living cells are highly dynamic systems that utilize a large variety of proteins to organize their
architecture and to carry out cellular functions. The spatial organization of these proteins and their
structures are crucial for their biological function. Of particular interest has been the advances in
method advancement in which the characterization of structures and dynamical properties of
proteins has often led directly to a profound understanding of the nature and mechanism of their
functional roles.
To date, multiple biochemical and biophysical techniques exist to obtain structural information for
protein complexes. As described in Table 1, classical high-resolution techniques include X-ray
crystallography, NMR spectroscopy, and cryogenic electron microscopy (Cryo-EM). X-ray
crystallography and NMR have contributed the most atomic models of protein in protein data bank
(PDB) on which investigators rely for basic research to drug discovery. However, both methods
have fundamental challenges: X-ray crystallography requires high-quality crystals suitable for
structural analysis, and they are not applicable for protein dynamics studies. NMR is limited to
small proteins. If the protein complex has a large size and is difficult to crystallize (e.g., integral
membrane proteins), it’s formidable to obtain protein structure. Recently, the ‘resolution
revolution’ in cryo-EM empowers the structural biologist to obtain atomic level structural
information for protein complexes that are not amenable to X-ray crystallography or NMR.[1]
Despite the increased capacity, the requirement for plunge freezing prior to characterization in
Cryo-EM, make it impossible to interrogate protein dynamics directly.[2] Further, proteins of MW
less than about 50 kDa are currently too small to be visualized at high resolution by cryo-EM,
leaving most protein molecules in the cell beyond the reach of this powerful structural technique.[3]
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Mass spectrometry fills the gap to provide protein dynamic information and medium-to-high
resolution (i.e., regional and residue-specific insights) structural information in solution. The high
sensitivity of modern MS enables the protein sample to be measured within pico-nanomole scale,
and MS-based method are not (often) restricted by protein size. Although a single MS technique
cannot provide a protein’s structure with atomic-level resolution and coordinates, an integrative
approach or a combination of MS with classical methods (X-ray, NMR, Cryo-EM) can be
extremely informative.
Table 1. Comparison of mass spectrometry with classical structural methods

Methods

Information

Advantages

Limitation

X-ray
crystallography

Atomic level

High resolution; applicable for
different sized protein

Static images with little dynamic
information; time-consuming for
crystallization; relatively high
sample amounts

NMR
spectroscopy

Atomic level

High resolution; protein
dynamic studies

Limited to protein size (~35 KDa);
high concentration (2-5 mM),
possibly leading to sample
aggregation

Cryo-EM

3 to 12 Å
resolution

High resolution; applicable to
studies of large protein
complexes and protein
dynamics

Limited to small and dynamic
proteins; high start-up cost

Integrative mass
spectrometry

Residue or
peptide or spatial
resolution

Fast; high sensitivity; few
restrictions on MW; informs
on protein structure and
dynamics (Table 2)

Moderate resolution; can be
combined in an integrative
approach.

Nevertheless, structural biology becomes increasingly integrative, in that information from a range
of complementary techniques can be combined not only to determine the structure of a
protein/assembly, but also to interrogate conformational dynamics and to study other motions
important for function. In the following section, we will introduce each technique and discuss the
4

role mass spectrometry has in the structural biology toolkit; the approach is sure to reveal the
secrets of how proteins perform the vast array of functions and interactions essential for life.
1.2.1. X-ray crystallography
The method of protein crystallography originates from the discovery of X-rays by Wilhelm Conrad
Röntgen, and the subsequent developments by Max von Laue, who was first to observe diffraction
of X-rays to reveal the wave nature of X-rays. However, the first protein structure (myoglobin)
was determined 45 years later to initiate protein crystallography, which gave the authors, Max
Perutz and John Kendrew the Chemistry Nobel Prize in 1962.[4] X-ray crystallography provides
detailed structural information at atomic-level resolution and is one of the most widely used
strategies to investigate structures of proteins and protein complexes.[5] The electron-density map
generated from X-ray diffraction data displays the overall structure of the protein or protein
complex, as well as the amino acid residues involved in the protein interfaces at atomic resolution.
1.2.2. NMR spectroscopy
NMR spectroscopy is a method that provide structural information about proteins or protein
complexes in solution. It has an advantage over X-ray crystallography because it can be used to
study protein kinetic and dynamics at the atomic level. The solution structural information
obtained by NMR is dynamic and closer to physiological conditions. In that way, NMR
complements the static structural information from X-ray crystallography.[6] On the other hand,
NMR has several limitations: 1) routine NMR is applicable for proteins in the size range between
5 and 35 kDa.[7] Most important protein complexes exceed 35 kDa. For large protein complexes,
their NMR spectra present many overlapping peaks that are difficult to be resolved and assigned.
2) NMR require relatively high concentration of sample (2-5 mM), possibly causing protein

5

aggregation. 3) NMR provides limited structural information at the protein–protein interaction
interfaces.[8] 4) Although solid-state NMR has been used to determine the structure of reconstituted
membrane proteins, its application in membrane protein complexes has not been reported. [9]
1.2.3. Cryogenic electron microscopy
Unlike X-ray crystallography and NMR spectroscopy, Cryo-EM allow direct visualization of
macromolecular protein complexes, often in physiologically relevant media (e.g., in a cell) at
cryogenic temperatures. In general, cryo-EM requires that the complexes analyzed be > 150 kDa.
Although a homogeneous sample is ideal for cryo-EM, in practice, generating 3D classes of
particles allows researchers to reveal multiple conformations within a sample and select the model
that achieves the highest resolution for further refinement.[10] The advantage of Cryo-EM over Xray crystallography is that Cryo-EM doesn’t require crystals, which is difficult for certain protein
systems such as integral membrane protein or virus particles. Also, it enables investigators to see
how biomolecules move and interact when they perform their functions, which is nearly
impossible when using X-ray crystallography.
1.3. Integrative mass Spectrometry
The term proteomics, proposed by Marc Wilkins in 1996, denotes the “PROTein complement of
a genOME.[11] Two transforming technologies have been crucial to the rapid advancement of
proteomics: (1) new strategies for peptide sequencing that use mass spectrometry (MS) utilizing
“soft” electrospray ionization (ESI) and matrix-assisted laser desorption/ionization (MALDI), and
(2) the concurrent improvement, miniaturization and automation of liquid chromatography (LC).
Together, these technologies allow the identification of peptides in a high throughput fashion and
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enable not only proteomics, aimed at primary structure, but also structural proteomics for highorder structure.
Mass spectrometry (MS) has evolved as a new, integrative tool for in structural proteomics.[12]
Integrative mass spectrometry (IMS) provides a plethora of information, from protein primary
structure and post-translational modifications (PTMs) to higher-order structure, protein dynamics
and interactions.[13] Conceptually, IMS-based techniques can be classified in two main categories
according to the analytes that are measured in the mass spectrometer, namely native MS and
labeling (footprinting) MS. Table 2 lists the pros and cons of commonly used structural MS
techniques. In complement with classical methods, MS can provide moderate to high structural
resolution (peptide or residual level information) but has fundamental advantages in sample size
(picomole and less) and high-speed turnaround of sample processing and data analysis. Even for
those proteins with higher structural heterogeneity that are not compatible with classical methods,
MS still can yield valuable structural information.
Specifically, native MS explores the ability of electrospray ionization (ESI) to maintain noncovalent interactions upon ionization, preserving tertiary and quaternary structure of protein in the
gas phase.[14] Native MS is an enabling technology for protein subunit stoichiometry, architecture,
and protein-ligand interactions.
Compared to native MS, labelling or footprinting approaches have the advantages of classical
proteomics methods that utilize bottom-up analysis. In these methods, the protein is labelled in
solution, followed by proteolysis to peptides. After digestion, the analytes are submitted to MS
analysis either qualitatively or quantitatively. Related methods are chemical crosslinking (XL),
hydrogen-deuterium exchange mass spectrometry (HDX-MS), and irreversible protein
7

footprinting. Each of these MS-based approaches provides a different type of structural
information and, in many cases, integrating data from several of these methods can add significant
new informative. In addition, MS can complement classical methods to unravel a more
comprehensive picture of a protein. For example, combinations of MS-based limited proteolysis
with a static protein structure obtained by using X-ray crystallography can allow one to monitor
conformational transitions upon substrate binding;[15] For large protein complexes, which are
formidable to crystallize, MS-based cross-linking can bridge the gap between an EM experiment
and structure determination of any single subunits. [16]
Table 2. Common MS-based methods
Methods

Information Level

HDX

Able to locate binding site at peptide or residue level
when coupled with ETD fragmentation, measure the
dynamics and assess binding affinity, classify ligand
binding, identify remote conformation changes and
allostery.

Locate binding sites, guide alanine
scanning and protein design, evaluate
high-order structure for biosimilars
(approved by FDA), measure binding
affinity;

Protein
footprinting

Identify binding sites; measure protein dynamics
(e.g., protein fast folding or aggregation), detect
conformational change or allostery.

Provide information for protein-ligand
interaction, fast folding, aggregation and
conformational change.

CrossLinking

Provide constraints for placement of subunits or
domains in large protein assemblies.

Provide spatial information for EM,
study protein complex networks.

Determine stoichiometry and dynamics of protein
complexes, determine stability of complex,
accurately measure mass of each subunit, and
validate protein sequence identity.

Determine subunit stoichiometry for
protein complex, screen ligands based
on their specificity and complex
stability.

Determine the unknown sequence of protein, locate
and identify post-translational modifications.

Identify novel ligand or receptors with
unknown sequence or post modification

Native Spray

De Novo
Sequence

Applications
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1.4. Protein footprinting
1.4.1. The principles of protein footprinting
“Protein Footprinting” characterizes protein structure by using chemical reactions to determine
solvent accessibility of the backbone or side chains of a protein.[17] The footprinting based
technologies was initially established as a quantitative biophysics tool for studying DNA-protein
interactions.[18] Advances in chemical labeling and mass spectrometry revolutionized protein
footprinting and extended this method to study numerous protein system (e.g., immune complex,
metal-binding proteins, or membrane protein).

Figure 1. Workflow for protein footprinting.Typically, the protein of interest is labeled with a reagent in solution,
followed by a rapid quench. The labeled protein is then proteolyzed by protease in-gel or in-solution. The resulting
peptides are submitted for tandem MS for peptide identification and quantitative analysis.

Protein footprinting encompasses different labeling strategies depending on the type of chemistry
involved.[19] Although those methods have varied labeling strategies, they share a common generic
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workflow; (1) a labelling experiment is performed in solution, (2) the proteins are digested with a
protease, and (3) the sites of modification are identified by MS (Figure 1). Broadly speaking,
protein footprinting can be classified into reversible labling and irresversible labeling. As shown
in Figure 2, the reversiable labling almost exclusively target on the amide bond at backbond of
protein, whereas the irresverisble labeling utilize differnt chemistry to label protein side-chains.
1.4.2. Reversiable labeling (e.g., HDX-MS)

Figure 2. Protein regions targeted by protein footprinting.(a) HDX is the canonical reversible labeling method that
exchanges labile hydrogens of the amide bond of proteins with D2O from the surrounding water. (b) Unlike HDX, the
irreversible labeling targets the sidechain of a protein to form stable covalent bond compatible with classical bottomup analysis procedures (e.g., overnight and high-temperature digestion).

HDX-MS is a reversible and nearly universal approach to footprinting. The protein sample is
incubated in deuterium-rich solutions (D2O) under uniform pH and salt concentrations. The D2O
exposed protein region undergoes rapid amide H → D exchange, whereas tightly folded or
hydrogen bonded areas are much more protected in HDX, resulting in slow isotope exchange that
is mediated by the structural dynamics of the protein. The deuterium content of peptic peptide
fragments are then measured by MS to derive structural information. Theoretically, hydrogen–
10

deuterium exchange occurs on three types of X-H bond in proteins: those in inert carbon-hydrogen
bonds, those in side-chain functional groups, and those in amide functional groups (also called
backbone hydrogens). Hydrogen atoms in side-chain functional group (i.e., O–H, N–H, and S–H
groups) are labile, which exchange fast and then back exchange rapidly with the surrounding water
during separation and analysis. Obviously, this H - H conversion is not detectable by MS. On
contrary, the exchange rates of hydrogens in carbon-hydrogen bonds are too slow to observe. In
this case, only the backbone hydrogens (amide bond) are measurable to afford a readout of protein
structural information (encoded in purple, Figure 2a). Because HDX-MS utilizes D2O as reagent
to label protein, HDX-MS is advantageous as it represents a minimal perturbation of the protein.
The major limitation of HDX-MS is that resolution of deuterium residual level localization
information is limited to the length of the peptide generated during proteolysis. Also, the backexchange occurring during long sample cleanup causes difficulties to extend HDX-MS for in-cell
structural studies.
1.4.3. Irreversible labeling
Hydroxyl radical footprinting (HRF) is the most common of the approaches that impart irreversible
changes on a protein, and it is used most commonly on synchrotron or photolysis-based systems
(e.g., fast photochemical oxidation of proteins or FPOP is the most common photolysis platform).
Other chemical footprinting reagents range from those having modestly broad reactivity (e.g.,
carbenes,[20-22] iodide radical,[23] sulfate radical anion,[24] and carbonate radical anions[25]) that can
be generated on the FPOP platform to highly specific amino-acid labeling reagents (e.g.,
diethylpyrocarbonate,[26] glycine ethyl ester,[27] benzyl hydrazide[28]) that require no special
platform. Instead, the latter are generated slowly by chemical reactions in solution. Interest in new
reagent development is growing as investigators search for broad and comprehensive coverage.
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No single reagent will be equally reactive with all amino-acid residues, and as a result,
modifications concentrate on reactive residues. Reagents with complementary reactivity are
needed to afford high coverage.
1.5. Footprinting platform
1.5.1. Fast photochemical oxidation of proteins (FPOP)

Figure 3. FPOP flow system.Samples with an exclusion volume fraction of 20-25% (the volume not irradiated by
laser, sandwiched in between plugs of the irradiated solution) are advanced at an adjusted rate by a syringe pump.
Samples then flow into collection vials containing catalase and methionine that destroy residual amounts of hydrogen
peroxide.

FPOP is a method to fast footprint proteins by radicals generated by laser photolysis in a flow
system (Figure 3). The prototype reactive species in FPOP is •OH, which provides nearly general
and fast reactions. Its design enable three beneficial properties for FPOP: first, FPOP experiments
involve flowing the sample of interest through a capillary where a protein solution passes through
a window with an adjusted flow rate. This fluidics setup ensures each “plug” of solution is
irradiated only once. Second, the lifetimes of the primary •OH are controlled within sub-ms
timescale with scavenger. Therefore, FPOP is an appropriate method to study fast protein events
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(e.g., protein fast folding or unfolding).[29] Third, the FPOP platform can incorporate two or more
laser sources with distinct wavelength. Krypton fluoride (KrF) excimer laser is the commonly used
laser source for FPOP experiments, which provides ns pulses of UV laser at 248 nm. Another
pulsed 355 nm Nd-YAG laser can be used to photolyze diazirine, for example, to produce carbenes
for protein footprinting.[22] These two-laser source can enable development of new reagents for the
FPOP platform and provide broader reactivity coverage and higher resolution for protein structural
characterization. The development of reagents in FPOP and their chemical reactivities were
reviewed by Zhang et al.[30]

Figure 4. The photolysis of hydrogen peroxide and diazirine at FPOP platform

To date, the FPOP platform has been successfully applied to solve problems in structural biology.
The application of FPOP to different biological systems are reviewed in several articles.[31, 30, 32]
Specifically, FPOP is applied to follow protein conformational changes, protein folding, in-cell
labeling, and amyloid formation, identify protein/protein interfaces, and membrane protein studies.
Despite the successful application to date, there remains limitations for hydroxyl radical
footprinting by FPOP. First, the mass shift (+16 Da) generated by oxidation is not biorthogonal.
This +16 Da mass shift can be introduced either prior to or after laser irradiation, especially for the
most •OH reactive residues (e.g., Met and Trp). A control measurement is used to minimize this
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artifact. Second, although •OH theoretically can react with all amino acids, rate constants span
nearly three orders of magnitude, thus missing the less-reactive residues (e.g., Gly, Ala, Asp, Asn,
Ser, Thr) that cannot be competitively footprinted, whereas reactive sulfur and aromatic amino
acids are preferentially modified. To meet this challenges, different reagents have been developed
in FPOP which has different preference to label amino acids. Third, another problem occurs in
studies of integral membrane protein (IMP).[33] IMPs contain a large hydrophobic transmembrane
domain that present challenges for •OH labeling because both H2O2 (•OH precursor) and •OH are
water soluble, and only residues in contact with H2O2 can be footprinted. Other problems and
possible solutions in the application of FPOP platform for IMP will be discussed in later chapters.
1.5.1 X-ray-based synchrotron footprinting
X-ray-based synchrotron footprinting is platform used to study solution-state structure and
dynamics of proteins.[34] This platform employs X-ray beams produced by synchrotron radiation
to generate •OH that label water-accessible residues of proteins on the microsecond to millisecond
timescales.

(a)
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(b)
Figure 5. The synchrotron platform for protein footprinting.National Synchrotron Light Source II (NSLS-II) at
Brookhaven National Laboratory (top). The X-ray irradiation of water to form activated water and a dry electron.
The dry electron deposits its energy in discrete ionization of other water molecules while the activated water reacts
with another water molecule to produce •OH for protein footprinting.

In the synchrotron platform, the radiolysis of water with photons in the kilovolt X-ray range
transfers the energy of photon to an electron, which is then ejected from water molecules (Figure
5a). Although the X-ray could directly target the protein sample in solution, the protein under
study has a vastly lower concentrations than the solvent such that X-rays target bulk water
efficiently and not interact measurably with the protein directly. The electrons are then thermalized
(dry electrons) and deposit their energy in discrete ionization of other water molecules. This
activated water is produced very rapidly in spurts (in femtoseconds), and it reacts with another
water molecule to produce diffusible •OH that appears in the bulk solvent on the nanosecond
timescale, according to the reactions outlined above.[35]
X-ray footprinting afford applications in many biological systems, and these are well discussed in
several reviews.[34] Because X-ray directly irradiate water to generate •OH, it minimizes sample
perturbation. Further, the fast-labeling make X-ray footprinting an appropriate method for probing
protein structure and dynamics.
1.6. The application of fluorinated reagent in structural proteomics
Over the past decades, fluorine chemistry has been revitalized. Advances in fluorine chemistry
enhance our understanding of how “F” profoundly affects molecular structure, reactivity, and
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function. This revitalization bears fruit in the fields of materials, polymers, agrochemicals, and
pharmaceuticals, and undoubtedly, will extend beyond these fields.

Figure 6. Representative fluorinated reagent development for protein structural studies.(a) The intramolecular
rearrangement of diazirines to an alkene (Pathway b) upon activation can be avoided when the two adjacent hydrogens
are replaced by fluorine (Pathway a). (b) Examples for anesthetic photoaffinity labelling probes.

We recently reviewed the application of fluorinated reagent in structural proteomics (Angew. Chem.
Int. Ed. 10.1002/anie.201907662). We pointed out how fluorine-containing reagents can play a
unique role in structural proteomics, a new frontier for fluorine chemistry. It’s well known that F
enables fine-tuning of molecular properties. For example, as shown in Figure 6, fluorinecontaining compounds are often used as inhaled anesthetics. Fluorination increases the anesthetic
potency and preserves pharmacological properties. Fluorine-substituted compounds are often
nonflammable, poorly lipid soluble, and resistant to metabolism, facilitating the induction of
anesthesia, and permitting precise control of anesthetic concentrations. To locate the protein
16

binding sites for alkyl anesthetics, several investigators took advantage of fluorine properties and
placed the F’s adjacent to a terminal diazirine group to enhance labeling efficiencies. An
undesirable reaction for a carbene is an intramolecular C-H bond insertion to generate an alkene.
This undesired reaction can be avoided if the two adjacent hydrogens are replaced by fluorine
atoms or aromatic rings.
The beneficial properties of F depend on its strong electronegativity, high hydrophobicity, good
thermal and chemical stability, and strength of the X−F bond. These attributes provide rationale for
a hypothesis that new reagent development in this area will meet new challenges in structure
determination and structural proteomics.
We identify four contributing factors for the role of F in structural proteomics:
(1) The X-F bond is strong, enabling reagents that contain X-F to retain appropriate aqueous
stability commensurate with biochemical experiments. Protein modification needs to occur under
physiologically relevant conditions (i.e., usually < 37 ⁰C, pH 6–8, in aqueous milieu with mM
buffer and other salts). The successful use of reagents, including sulfur (VI) fluorides,
fluorophosphonate, and fluoromethylketone is convincing that reactive fluorine-containing
reagents are compatible with aqueous environments yet dramatically more robust than the other
halide counterparts.
(2) The presence of fluorine can improve labeling efficiency. TPDs and fluorinated azides can
avoid side rearrangements because strong C-F bonds are reluctant to undergo rearrangement. The
•CF3 is more reactive than its methyl radical analog owing to pyramidalization of •CF3 and the
strong σ-inductive effect, both enabled by fluorine.
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(3) Fluorine substitution can retain drug efficacy (e.g., inhaled anesthetics), suggesting a
partnership between fluorine therapeutics and structural proteomics. In fact, drugs with one or
more fluorines have become commonplace.
(4) The use of fluorine can introduce some issues. The synthesis of fluorine-containing reagents is
usually more difficult than that of their non-fluorine siblings. The increasing degree of fluorination
reduces reagent solubility in aqueous milieu.
In the following chapters 1, 2, 3, we will discuss the development of several fluorinated reagents
for protein structural elucidation and their application to different footprinting platform and
biological system.
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Chapter II: Laser Initiated Radical
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2.1. Abstract
We describe a novel, laser-initiated radical trifluoromethylation method for FPOP and establish its
broad amino-acid site reactivity. Trifluoromethyl radicals (•CF3) react with 18 of 20 common
amino acids (90% coverage) including Gly, Ala, Ser, Thr, Asp, Glu that are relatively “silent” with
•OH. This new approach to footprinting is a bridge between trifluoromethylation in materials and
medicinal chemistry and structural biology and biotechnology as exemplified with applications to
a membrane protein and the myoglobin model system. Results show that the approach is sensitive
to conformational changes and solvent accessibility of proteins. Further, additions of
trifluoromethyl groups increases hydrophobicity, suggesting opportunities transmembrane domain
labeling.
2.2. Introduction
Successful trifluoromethylation (CF3) chemistry in pharmaceuticals,[1] agrochemicals,[2] and
specialty materials[3] show that the addition of CF3 can affect profoundly a substance’s physical
properties, reactivity, biological activity, solvency, and stability. Figure 7 shows a wide
application of CF3 chemistry in many aspects of industry. However, the near absence of fluorine
in the biosphere and the difficulty of incorporating CF3 moiety into molecules have impeded new
applications. Thus, advances in trifluoromethylation could be of high importance biology and
protein biochemistry.
Protein modification especially footprinting is one area that can take advantage of the special
features of trifluoromethylation. It is of growing interest because it offers an opportunity to
determine coarse-grained protein structure particularly when NMR, X-Ray, and Cryo-EM fail.[4]
HDX-MS is a reversible and nearly universal approach to footprinting and interrogating high order
structure,[5] but requires fast workup to minimize back exchange. A complementary strategy is to
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use chemical reagents that irreversibly react with specific amino-acid side chains,[6] but reaction
rates are slow and reactions not general. A third approach is use reactive species (prototype is •OH)
to provide generality and high reaction rates.[7] Of the two commonly used platforms (radiolysis
and laser photolysis), the latter implemented as FPOF ( see figure 2) affords a ready opportunity
for broad-based implementation especially if the number and kinds of reactive species can be
expanded.[8]

Figure 7. The wide application of CF3 chemistry in different areas

Protein footprinting with reactive species (•OH, carbenes[9]) is becoming effective in structural
proteomics because it modifies proteins before they undergo conformational change. Although
•OH theoretically reacts with all amino acids, rate constants span nearly three orders of magnitude,
thus indicating that less-reactive residues (e.g., Gly, Ala, Asp, Asn, Ser, Thr) are not measurably
footprinted whereas reactive sulfur and aromatic amino acids are preferentially modified.[10] Using
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epitope mapping as an application, we see that Phe and Cys, which are highly reactive with •OH
have the lowest probability to be at an interface, whereas Gly, Ala, Asp, Asn, Ser, and Thr are
likely candidates for an epitope.[11] Thus, no single reactive species will be a panacea for the wide
variety of protein footprinting requirements, thereby necessitating development of other reactive
species.
Pioneering work by Dolbier and Minisci demonstrated that perfluoroalkyl radicals not only
undergo addition reactions with alkene and aromatic rings,[12] it even abstract hydrogen from
alkanes.[13-14] The rate constant studies also reveal that perfluoroalkyl radicals have much higher
reactivities than those of the analogous alkyl radicals, and their rate constant are considerably
larger in aqueous media than in nonpolar organic solvents.[15-16]
We hypothesize that •CF3 has promising properties in protein footprinting, extending successes
elsewhere to structural proteomics and biotherapeutics: first,

•CF3 is highly reactive and

hydrophobic, suggesting even higher reactivity in water, the medium of proteins.[17] Second , the
absence of endogenous fluorine or CF3 moiety

in biological macromolecules make

trifluoromethylation a promising biorthogonal probe. That is, the CF3 can be only introduced from
footprinting rather than another oxidation resource. Third, •CF3 is bio compatible. Baran and
coworkers[18] demonstrated that •CF3 modified beta-lactamase retained functional activity after
isolation. The incorporation of CF3 moiety into pharmaceuticals are well-known because CF3 adds
stability to molecules owing to strong C-F sigma bonds and steric resemblance to C-H. Last but
not least, owing to the hydrophobicity of •CF3, perhaps the hydrophobic nature of •CF3 makes it
suitable for studies of membrane proteins by using appropriate membrane-soluble precursors.[19]
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Radical trifluoromethylation via photolysis can be traced back to Golitz[20]. Since then, powerful
methodologies for trifluoromethylation have been spawned by the groups of

Meijere,[21],

Langois,[21] MacMillan,[22] Baran[23] and others,[24-29] who increased the scope and generality of
trifluoromethylation. Macmillan et al. [12] showed that radical trifluoromethylation can occur under
photoredox-catalysis conditions. These approaches use metals and organic solvents, not the
medium of biology. Taking a lead from Baran,[30] we developed a means to generate and utilize
•CF3 in aqueous buffer solutions by using a pulsed laser suitable for protein footprinting.
In this chapter , we implemented laser-initiated trifluoromethylation and tested its applicability for
footprinting a peptide and three proteins using a FPOP platform, which already has been used to
follow protein conformational changes, protein folding, in-cell labeling, and amyloid formation, to
identify protein/protein interfaces, and to accommodate other new footprinting reagents.[8]
2.3. Materials and methods
2.3.1. General information
Unless otherwise noted, all materials were used as received from commercial sources without
further purification. Equine skeletal myoglobin, apo-myoglobin, beta-lactoglobulin, neuropeptide
Y fragment 18-36 (NPY 18-36, Human, Porcine), sodium triflinate (CF3SO2Na), 2-iodoacetamide,
hydrogen peroxide, phosphate buffered saline (PBS, 0.01 M phosphate buffer, 0.0027 M potassium
chloride and 0.137 M sodium chloride, pH=7.4), urea, water, acetonitrile, formic acid was obtained
from Sigma-Aldrich Chemical Company (St. Louis, MO, USA). Membrane protein VKOR
(PDB3KP9) was provided by Dr. Weikai Li from DBBS at Washington University in St. Louis.
Trypsin and TECP-HCl were purchased from Thermo Fisher Scientific. The concentrations of all
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the protein stock solutions were determined by UV absorption using Thermo Scientific™
NanoDrop™.
2.3.2. Preparation of sample solution
2.3.2.1. NPY 18-36 sample preparation
NPY 18-36 sample was prepared by adding NPY 18-36 (4 μL,125 μM in PBS buffer) into 36 μL
PBS buffer. The protein solution was then added H2O2 (5 μL, 100 mM in water) and CF3SO2Na (5
μL, 100 mM in water) sequentially to make a solution of 10 μM NPY 18-36, 10 mM H2O2, 10 mM
CF3SO2Na in PBS buffer.
2.3.2.2. Ubiquitin sample preparation
Beta-lactoglobulin solution (5 μL ,100 μM in PBS buffer) was added with sodium triflinate (5
μL,100 mM in water) and H2O2(5μL,100mM in water) in 35 μL PBS buffer , which result in a
solution of 10 μM beta-lactoglobulin and 10 mM CF3SO2Na and 10 mM H2O2.
2.3.2.3. Membrane protein VKOR sample preparation
3 mg DDM (Anatrace D310) was dissolved in 10 g PBS buffer (0.01 M phosphate buffer, 0.0027
M potassium chloride and 0.137 M sodium chloride, pH=7.4). The resulting 0.03% DDM PBS
buffer solution was vortexed at 2700 rpm speed to make sufficient mix. After 1 min, the solution
was cooled in ice for 10 min. 2 μL VKOR stock solution (50mg/mL or 1570 μM) was then diluted
in 31 μL 0.03%DDM PBS buffer to make a VKOR solution (100 μM in 0.03%DDM). VKOR
solution (5 μL ,100 μM in 0.003%DDM PBS buffer) was added with sodium triflinate (5 μL,100
mM in water) and H2O2 (5μL,100mM in water) in 35 μL 0.03%DDM PBS buffer , which result in
a solution of 10 μM VKOR and 10 mM CF3SO2Na and 10 mM H2O2.
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2.3.2.4. Myoglobin sample preparation
Apo and Holo Myoglobin were prepared by diluting Apomyoglobin (32 μM in pH=7.4 PBS buffer
and Myoglobin（129 μM in pH=7.4 PBS buffer）into PBS buffer. H2O2 and CF3SO2Na are then
added sequentially to make a solution of 10 μM protein, 2 mM H2O2, 40 mM CF3SO2Na in PBS
buffer.
2.3.3. Radical trifluoromethylation of protein in FPOP system
The 50 μL sample in syringe was carried with syringe pump. A flow rate (19.5 μL/min) was
calculated on the basis of laser spot width (2.5 mm) and laser frequency (7.2 Hz) to ensure 15%
exclusion volume. The sample solution was irradiated by a 248 nm KrF excimer laser (15mJ/pulse,
GAM Laser Inc., Orlando, FL) when passed through capillary window (Figure 3). The flow rate
was adjusted with syringe pump and the laser pulse frequency was controlled by an external pulse
generator (B&K Precision, Yorba Linda, CA). Presumably every portion of sample solution are
only subjected to one laser shot. All samples were collected in vials containing 10 μL of 500 nM
catalase and 7 mM methionine, protecting protein from further oxidation by H2O2.
2.3.4. Proteolysis
After labeling, triplicate protein samples were digested by trypsin. Briefly, the protein was
precipitated with pre-cold acetone (-20 oC) and stored in freezer for 12 hours. The supernatants
were discarded after centrifuge. The resulting protein pellet were denatured with 10 μL 8M urea
and then reduced by TCEP-HCl (0.5 μL,50 mM) at 37 oC for 30 min, followed by cysteine
alkylation with iodoacetamide (0.5 μL,100 mM) at room temperature and in the dark for 30 min.
The denatured proteins were digested by trypsin with a final protease to protein ratio of 1:20 to
1:100 (w/w) at 37 °C for 12 h. Finally, 1 μL formic acid was added to stop the digestion.
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2.3.5. Mass Analysis
2.3.5.1. Global analysis of protein by mass spectrometry
Except VKOR protein, global mass spectra were taken with Bruker Maxis Q-TOF mass
spectrometer. The instrument setup for protein analysis was similar to that reported previously.[31]
2.3.5.2. Tandem MS/MS analysis
After the digestion, an aliquot (5 μL) of sample was loaded onto a custom-built silica capillary
column packed with C18 reversed-phase material (Waters Symmetry ,5 μm, 100 Å, 75 μm ×30
cm;). The HPLC gradient for myoglobin/apomyoglobin/beta-lactoglobulin was set as follows:
from 2.5 % Solvent B (80 % acetonitrile,0.1 % formic acid) to 40 % Solvent B over 50 min, then
jumped to 98% Solvent B over 6 min at a flow rate of 0.45 μL/min followed by a 10 min reequilibration step. The HPLC gradient for VKOR protein was set as follows: from 2.5 % Solvent
B (80 % acetonitrile,0.1 % formic acid) to 40 % Solvent B over 30 min, then increased to 65%
Solvent B over 20 min, finally ramped to 98 % over 6 min followed by a 10 min re-equilibration
step. A Q Exactive Plus hybrid quadrupole orbitrap mass spectrometer coupled with a Nanospray
Flex ion source (Thermo Fisher, Santa Clara, CA) was utilized for MS analyses. The instrumental
parameters were set as follows: spray voltage of 2.5 kV; capillary temperature of 250 °C; The Q
Exactive Plus was operated in data-dependent mode. MS spectra were acquired in the orbitrap
(m/z 300−1600) with a resolution of 70 000 at m/z 400 for MS1 and 17 500 at m/z 17 500 for
MS/MS. The five most intense ions were selected for HCD fragmentation at an automatic gain
control (AGC) target of 200 000. Previously selected ions were dynamically excluded for 8 s.
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2.3.6. Data analysis
LC-MS/MS raw files were imported into the Byonic™ Software (Protein Metrics, San Carlos, CA,
USA) coupled with an in-house database. Byonic™ processing of the LC-MS/MS data of the
trypsin-proteolyzed CF3- modified samples showed 96% sequence coverage for the triplicate Holo
/Apo myoglobin complexes. We chose 10 ppm precursor mass tolerance, 60 ppm fragment mass
tolerance, and CID/HCD fragmentation. The accuracy of mass assignment on each fragment ions
are double-checked with custom program Thermo Xcalibur. We calculated the ppm for all crucial
fragments ions that assigns CF3 modifications on 18 different amino acids. The ppm values of each
crucial fragment ions were added at the legend of each mass spectra. Modification fractions for
certain peptides were interrogated with Byologic™ software (Protein Metrics, San Carlos, CA,
USA) and double-checked with custom program Thermo Xcalibur. Modification sites on the
peptide were assigned on the basis of product-ion spectra (MS/MS data). The assignments were
further validated by manual inspection of their accurate mass and product-ion spectra. Extracted
ion chromatograms (XIC) ratio are calculated based on the following equation:

2.3.7. Density functional theory (DFT) calculation
The DFT calculations were performed by using Gaussian 09 software package for windows. The
optimizations of the reactants, intermediate, products and transition states were done using the
hybrid functional B3LYP and basis set 6-31G(d,p). Frequency calculations were carried out to
ensure that the structures obtained correspond to minima in the potential energy surface. The
transition states were determined using QST2 method which is part of Gaussian 09 software. The
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transition state structures showed one negative frequency corresponding to the desired reaction
and further confirmed by intrinsic reaction pathways were calculated to establish that the transition
states connect the reactants and products. The relative energies of the structures were computed
using the total electronic and thermal energies after applying temperature corrections. Ethyl phenol
was used as a model phenolic compound for studying the mechanism of the reaction of tyrosine
with CF3 radical.
2.4. Result and discussion
2.4.1. The optimization of CF3 radical (•CF3) protein footprinting

Figure 8. Optimization of CF3 radical protein footprinting

We begin with trifluoromethylation of the neuropeptide Y 18-36 (NPY18-36) as a model for
method development. We actualized the transformation by exposing NPY18-36 to laser irradiation
in the presence of H2O2 and the water-soluble salt, NaSO2CF3 (Entries 5, 6, 7, 8, Figure 8), but
found no detectable CF3-products in the absence of either peroxide or laser irradiation (Entries 2,
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4). We also used only solvent water as a control to test whether strong buffer anions account for
the poor reactivity, but similar results were obtained (Compare Entries 1, 3). With systematic
screening, we ultimately found conditions where peptide modification is extensive (Figure 9.).

Figure 9. Radical trifluoromethylation of NPY peptide. (a) Spectrum of unmodified NPY 18-36. (b) Mass spectra
after modification of NPY 18-36. (c) Zoom-in mass spectra of NPY 18-36 at +4 charge state. The sample includes
two different peptides. The NPY18-36 is peptide 1 marked with blue color. Peptide 2 is a [NPY+Asn] mutant marked
with red color. Both peptides are modified.
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2.4.2. The proposed mechanism
The trifluoromethyl radicals have exceptional reactivity characteristics due to their high
electrophilicity and pyramidal geometry. The structure, reactivity, and properties of fluoroalkyl
radicals were comprehensively reviewed by Dolbier in 1996.[32] As shown in Figure 10 , the
stability of the radical is strongly influenced by stereo electronic effects. The F atom, the most
electronegative element in nature, exerts a strong σ-inductive effect on the carbon radical. Further,
the F substituent behaves as a weak π-donor, whose lone pair, non-bonding orbital overlaps with
the singly occupied molecular orbital (SOMO) at carbon.[33] These two opposing effects act in
concert. In contrast to the planar CH3 radical, the CF3 radical is pyramidal and shows a large barrier
for inversion (Figure 10). The pyramidal shape of •CF3 is further confirmed by our DFT
calculation that shows F-C-F bond angle equals to 111.2o. The pyramidal structure was
experimentally established using the ESR technique.[34]

Figure 10. Structure of the •CF3 and stereo electronic effects and the energetics for an abstraction of an H atom by
using methane as a model. The energies refer to gas-phase species.

The key to forming •CF3 is the hydroxyl radical, formed by laser photolysis of HO-OH (Figure
11, pathway a). The major pathway may involve fast •OH pulsed oxidation of CF3SO2- to form
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•CF3 via an entropy-driven process. The electron-deficient •CF3 then readily adds to proteins
(pathway b). In an alternative minor pathway c), HO• directly abstracts H• from the protein to
produce a protein radical that either couples with •CF3 to provide a CF3-modified product or reacts
with HO• to generate oxygen-containing products. It should be noted that oxygen-containing
species could also come from an intermediate peroxyl radical, formed by addition of an O2 to
carbon radicals. The peroxyl radical may undergo subsequent reactions leading to the formation
of oxygen-containing product. We see products from both •CF3 and OH-oxidation (see Figure
10), but the CF3-substituted products dominate.

Figure 11. One proposed mechanism for radical protein trifluoromethylation.

To obtain further insight for the reaction mechanism, we recently performed, following our initial
communication, a DFT calculation to predict the pathway for •CF3 formation and the •CF3
reactivity with side chains. We chose 4-ethyl phenol as a model representing the side chain of
tyrosine. The first step is to form •CF3. On the basis of previously proposed mechanism,[35] the
•CF3 formation is driven by the electron abstraction by •OH. Our DFT calculation, however,
indicates an alternative pathway. Optimization of the •OH with the CF3SO2 anion yielded a
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structure in which the O-atom of OH radical is 2.25 Å from the S-atom of the CF3SO2 anion. The
product structure was optimized after making the S-O bond, and the resulting structure shows that
the formation of the S-O bond leads to the elongation of the C-S (from 1.892 to 1.920 Å) bond and
allows formation of •CF3 and HSO3- (bisulfate anion). A transition state could be obtained with a
relative energy of 2.96 kJ/mol above the reactant complex. The potential energy diagram and the

Relative Energy

structures are shown in Figure 12. We prefer this mechanism over the one we published originally.

Figure 12. Potential energy diagram for the generation of •CF3.The energies are given in kJ/mol obtained by DFT
calculation using the B3LYP/6-31G(d,p) method.

Next, we investigated the mechanism of •CF3 toward the side chain of tyrosine (modeled with 4ethyl phenol). Two possible pathways were explored assuming that the substitution occurs at the
ring carbon ortho to the phenolic OH group. The first pathway involves the abstraction of the OH
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hydrogen by the •CF3 followed by combination of the resulting radical with a second •CF3 to form
the keto form of the product. The second pathway assumes the reaction of the •CF3 with the ring
carbon and the resulting intermediate reacts with another •CF3 by abstracting either the CH
hydrogen or the OH hydrogen. In both pathways, the first step occurs with a transition state while
the second step is without a transition state as depicted in the energy level diagram in Figure 13.

Figure 13. Potential energy diagram for the reaction of •CF3 with ethyl phenol. The energies are given in kJ/mol
obtained by DFT calculation using the B3LYP/6-31G(d,p) method.

2.4.3. The evaluation of •CF3 as footprinter
Next, we applied the optimized conditions to test the reactivity of •CF3 to locate the reactive sites
for native protein structures, even in detergent media. The sites were identified by LC-MS/MS
analysis after tryptic digestion by using a canonical proteomics analysis. On the basis of product37

ion spectra (MS/MS), •CF3 reacts with 18 different amino-acid residues, comprising 90% of the
naturally occurring amino acids (see reference[36] support information page 11-28 for MS/MS data,

Figure 14. Representative MS/MS spectrum for CF3-modified on Alanine. The doubly charged unmodified peptide
267-283 (top) and CF3-modified peptide 267-283(bottom) from VKOR(PDB3KP9). The identification of y9 within 2
ppm (theoretical value 1007.4793) and y10 within 3 ppm (theoretical value 1146.5038) assigned the modification on
Ala-274. Note: Unmodified y10 and y11 were also observed in modified peptide 267-283 (bottom), indicating possible
chromatographic overlap of the labeling isomers between Ala-274 and Ala-272.
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Figure 15. Representative MS/MS spectrum for CF3-modified on Glycine. The of doubly charged unmodified peptide
267-283 (top) and CF3-modified peptide 267-283(bottom). The identification of y8 (theoretical value 988.4346) within
4 ppm and y7 (863.4258) within 5 ppm assigned the modification on Gly-276.
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Figure 16. Analysis of site reactivity for native protein higher order structure.At top panel, Beta-Lactoglobulin, VKOR
and Myoglobin were chosen as model test •CF3 chemical reactivities. At bottom panel, venn diagram compare •OHreactive residues (in blue) with •CF3-reactive residues (in yellow); residues in overlap are reactive to both OH and
CF3 radicals. •OH silent residues are in yellow crescent region.The chemical reacitivies of •CF3 is measured directly
with LC-MS/MS, while the reactivities of •OH is based on reference. [10]

and Figure 16).We illustrate the analytical approach, with a unique mass shift of +67.9870
detected by MS/MS, and an unexpected CF3 substitution on Ala-272 (Figure 14) and Gly-276
from VKOR (Figure 15). Remarkably, direct Csp3 C-H trifluoromethylation occurs on the side
chains of Gly, as well as Ala, Val, Ile, and Leu, showing a unique trifluoromethylation of aliphatic
Csp3-H bonds without Lewis-acid catalysis[37-38] or a cross-dehydrogenative coupling (CDC)
process.[39-40] Further, the side chains of Gly, Ala, Ser, Thr, Asp, Glu residues are relatively •OH
silent. Broad-based reactivity is usually desired in protein footprinting to maximize coverage.
We next determined whether •CF3 shows reactivity patterns consistent with protein structure and
solvent accessibility (i.e., is a good “footprinter”). Membrane proteins are challenging for
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footprinting because they are insoluble in water without detergent, and with detergent, only a
fraction of residues is solvent accessible. The membrane protein VKOR in pH 7.4 PBS buffer with
0.03% DDM detergent affords a soluble state. Photolysis in the presence of NaSO2CF3 leads to
outer membrane footprinting. Specifically, 10 residues (Y204, Y207, W208, P210, L271, A272,
A274, G276, Y277, P278) are modified in the fused extra-membrane, Trx-like domain (Figure
17).[41-42] The selectivity is due to the water solubility of the radical-precursor salt, which cannot
permeate the transmembrane domains even though the radical itself is hydrophobic. Membrane
proteins are the new frontier in structural biology because the proteins occur in in heterogeneous
media and are water insoluble.

Figure 17. Radical trifluoromethylation probe the topology of VKOR membrane protein.The salt-based precursor
CF3SO2Na only labels the segments outside of the transmembrane domain of VKOR. The modification sites on
VKOR protein are marked in orange.
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Figure 18. Comparison of modification extents of constituent peptides from hMb and aMb.(a) significant differences
in modification occur in the peptide 80-96, marked in red. hMb contains a helix region (F helix) in the region of
peptide 80-96 while aMb doesn’t form a F helix. (b) Modification ratios at the residue level (His, Phe and Tyr).

To test further its utility, we asked whether •CF3 can provide a meaningful footprint of protein
conformational change. We choose holo/apo-myoglobin (hMb/aMb) because these forms are
structurally different as demonstrated in many studies. Accurate masses of tryptic modified and
unmodified peptides in extracted-ion chromatograms are evidence that trifluoromethylation
affords reliable outcomes. Comparisons of holo and apo reveal that there are similar extents of
CF3-modification within the A-E, G and H helices, but dramatically different modification extents
for regions 80-96 (hMb 6.6% vs aMb 89.0%), which contains the F-Helix only in the holo form
(Figure 18). The results are consistent with top-down HDX[43] and NMR[44]. Readily detected
modifications in regions 1-16 (hMb 22.6 % vs. aMb 19.2 %), 32-45 ( hMb 3.1 % vs. aMb 4.0 %),
119-133 (hMb 2.6% vs. aMb 11.1%), 134-139 (hMb 3.8 % vs. aMb 2.8 %) are controls. Production spectra show a total of 17 total modified. residues, and those of histidine are consistent with
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the transition from unstructured to structure for hMb to aMb, a pattern found in the iodination
footprint[45]. For other aromatic residues, we found relatively extensive labeling at W7, W14 and
F43, indicating good •CF3 radical reactivity toward aromatic rings (Figure 18b).

Figure 19. EIC of wildtype and CF3-modified peptide 32-45 of aMb.The CF3 modified peptide observe longer
retention time in reserved-phase HPLC.

Even with a single CF3 replacement for F43 or H36, there is a significant shift to longer retention
times in reversed-phase HPLC (Figure 19), a shift due to the increasing hydrophobicity of the
CF3-modified peptides. This sharply contrasts with most other footprinting that utilizes hydrophilic
reagents. Indeed, the hydrophobic ∙CF3 points to new footprinting within transmembrane domains
by hydrophobic precursors, done by equilibrating hydrophobic precursors of •CF3 and related
radicals and submitting them to FPOP. One challenging example is locating steroid binding sites
in receptor proteins, recently done by photolabeling the binding site with steroids containing
reactive sites[46].
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2.3. Conclusion
This novel application in structural proteomics introduces for the first time the bio-orthogonal CF3
group onto side chains of proteins setting the stage for applications in biophysics and bio-.
therapeutics, perhaps even for demanding and intransigent human membrane proteins. Two other
opportunities follow: First, because •CF3 can be produced in biological buffers, we may be able
to synthesize fluorine-containing proteins for positron emission tomography (PET) tracers.[47]
Second, we can extend the sulfinate chemistry to design isotope-labeling and cross-linking
reagents that can be readily detected by mass spectrometry and other approaches (e.g., F-NMR).
Currently, we are investigating the mechanism, generality and versatility of protein
trifluoromethylation.
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Chapter III: Protein Footprinting by X-ray
Mediated Radical Trifluoromethylation
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3.1. Abstract
Synchrotron radiolysis generates hydroxyl radicals (•OH), which have been successfully used as
a footprinting reagent. Here, we describe a new method for radiolysis and footprinting, the
trifluoromethyl radical (•CF3), which is readily generated by •OH oxidation of sodium triflinate
(Langlois reagent). Upon X-ray beam exposure the reagent labels proteins extensively without any
additional chemicals and on the millisecond timescale. •CF3 is comparably reactive to •OH and
produces complementary footprinting. This and related reagents enable novel chemistry for protein
footprinting on the synchrotron platform.
3.2. Introduction
“Protein footprinting” characterizes protein structure by determining the solvent accessibility of
the backbone or side chains of proteins. Compared to other methods (e.g., NMR spectroscopy, Xray crystallography, or cryo-EM), protein footprinting is not restricted by protein size, bimolecular
media (including live cells and animals),[1] and can give fine-grained readouts of protein structure,
particularly when other methods fail.[2-3] Moreover, protein structure and dynamics can be
interrogated in physiologically relevant media. Footprinting is enabled by increasingly effective
liquid chromatography with tandem mass spectrometry (LC/MS/MS) that has been an enabling
tool in proteomics.
One approach to protein footprinting is irreversible labeling that forms stable modifications on
side chains. Among various reactive species, the prototype is hydroxyl-radical (•OH), which was
first introduced by Chance and co-workers for footprinting.[4] Although there are several methods
to generate •OH, the most common are synchrotron radiolysis of water and laser photolysis of
hydrogen peroxide.[5-7] The advantages of •OH compared to other irreversible labeling reagents
are its high reactivity, covering over one-half the common amino acids (AA), its size, which is
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comparable to that of water, and its polar nature compatible with soluble proteins. Other reactive
species include carbenes,[8-11] iodine radical,[12] sulfate radical anion,[13] and carbonate radical
anion.[14] Slower reacting reagents complement •OH and are generally AA specific (e.g., NEM,[15]
GEE,[16] BHD[17]) but can have broad reactivity (e.g., DEPC[18]). These latter reagents don’t require
special equipment, but they require longer time to accomplish the footprinting, thus posing a
potential perturbation of protein structure.
Since the advent of X-ray footprinting (XF) at 1999, XF has been applied to investigate protein
structure and dynamic in various biological system.[4] The wide application of X-ray footprinting
are reviewed comprehensively.[19] Like other •OH based footprinting approaches, XF technique
utilizes •OH as reactive species to paint the surface of protein. As shown in Fig. 19,[20] in X-ray
radiolysis, activated water is generated in spurs within a femtoseconds timescales. The diffusible
•OH stored in the bulk solvent which extend the •OH lifetime to nanosecond timescales. •OH can
be quenched by reactive species in the sample buffers or recombinate to form H2O2. Compared to
other techniques that generate •OH, X-ray footprinting has several features: first, pulses emitted
are less than a nano-second.The irradiation can be controlled within focused X-ray wavelength
range and with adjustable labeling time ( usually range to millisecond timescale). Second, •OH is
generated in situ by directly irradiating water, which is 55 M concentration in aqueous buffered
solutions. This high concentration make the “reagent” ubiquitous to protein surface. Third, XF
technique can be used with aqueous buffered solutions near physiological conditions or inside
living cells, and is therefore highly suitable for studying complex biomolecular systems. Fourth,
in the XF method, the extent of oxidation is increased with •OH concentration, which is related to
X-ray irradiation time or dose. XF provides a straightforward way to vary the •OH dose from 5-
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to 20-fold by varying the flow rate of the sample across the fixed size and flux density of an X-ray
beam.

Figure 20. Schematics of major reactions for X-ray radiolysis in dilute protein samples.Radiolysis of bulk water starts
with the ionization of water under 10-16 s (spur). The key product, •OH diffuses (10-7 s) out in the bulk and undergoes
reactions with the buffer and protein side chains. The former reaction, as well as various recombination reactions,
scavenge •OH and reduce the concentration of •OH in the bulk. Sufficient X-ray dose is needed to maintain a steadystate concentration of •OH. Figure 20 is cited from reference.[20]
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Table 3. Techniques generating •OH for protein footprinting

Techniques

Electron Pulse
Radiolysis

Energy Source

Chemistry

Notes
Pulses of electrons to
activate water to eject
electron; Mega-eV energy
may decompose protein.

Electron Pulse

Kilovolt X-ray induce
photoelectric effect that
transfer energy of photon to
an electron; Activated water
produce •OH.

Synchrotron
Radiolysis

X-ray

Laser Photolysis

Laser Beam

UV-light (usually 248 nm)
induced homolysis of H2O2.

Fenton Reaction

Iron Redox

Transition metal in lower
oxidation state catalyze the
generation of •OH.

High Voltage
Electrical Discharge

Electrospray create a plasma
around the needle. Corona
discharge produces •OH

Plasma; Electrospray

Our previous work, carried out on the fast-photochemical oxidation of proteins (FPOP) platform,
found that radical trifluoromethylation of proteins can be induced by using the Langlois reagent
(sodium triflinate), a water-soluble salt that undergoes oxidation by •OH, formed by photolysis of
HO-OH.[21] We presume that once •OH forms, it rapidly reacts with Langlois reagent, possibly
without a transition-state barrier, implying that •CF3 can be used in any system that utilizes •OH
or other strong oxidizing agents.[22]
X-ray-based synchrotron footprinting employs X-ray beams to generate •OH directly from water
with adjustable timescales appropriate for probing protein structures.[19] If the above hypothesis is
correct, radical trifluoromethylation can be driven by water radiolysis with a synchrotron . That
radiolysis forms •OH, suggesting that it can also produce •CF3 for synchrotron footprinting.
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In this chapter, we describe a test of feasibility and utility of CF3 footprinting as a complement to
that of •OH on the synchrotron platform. We found •CF3 was readily generated in synchrotron
platform to extensively label protein without any additional chemicals (e.g. peroxide, transition
metals) and within millisecond timescales by using sodium triflinate (Langlois reagent). In
comparison with hydroxyl radical(•OH) labeling, •CF3 can afford complementary chemical
reactivities and produce the similar footprinting pattern relevant to •OH. This reagent is the second
footprinting reagent enabled by synchrotron platform since the prototype radical •OH. The
experiment also serves as proof-of-concept experiment to demonstrate that synchrotron platform
could accommodate more novel chemistry for protein footprinting as long as the chemistry is •OH
driven. Further, to the best of our knowledge, it’s first example that use water as radical initiator
to produce •CF3 for trifluoromethyl functionalization.
3.2. Materials and methods
3.2.1. General information
Equine skeletal myoglobin, apo-myoglobin, sodium triflinate, phosphate buffered saline tablets
(PBS, pH = 7.4), urea, formic acids (FA), and trifluoracetic acid (TFA), acetonitrile and water were
obtained from Sigma-Aldrich Chemical Company (St. Louis, MO, USA). Except for sodium
triflinate (≥ 95% purity), all other chemicals are LC-MS grade. Trypsin was purchased from
Thermo Fisher Scientific. The Zorbax Eclipse XDB-C8 trap column (2.1 x 20 mm) was obtained
from Agilent. The silica capillary C18 column was custom-built with C18 reversed-phase material
from Waters Symmetry, 5 μm, 100 Å, 75 μm ×30 cm.
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3.2.2. X-ray protein footprinting
X-ray protein footprinting experiments were performed on beamline 3.2.1 at the Advanced Light
Source (ALS) at Lawrence National Berkeley Laboratory (LBNL). Protein samples for hydroxyl
radical footprinting experiments (XF-OH) were prepared reconstituting lyophilized apomyoglobin
or holomyoglobin in PBS buffer (pH 7.4) to yield a final concentration of 5 µM, and samples for
XF-CF3 experiments were prepared the same way except sodium triflinate was added to a final
concentration of 20 mM. All samples were prepared fresh and stored on ice until X-ray exposure
and were exposed using a capillary flow setup as previously described.[4-5,

7]

Samples were

collected in triplicate.
3.2.3. Enzymatic digestions
After labeling, triplicate protein samples were digested by trypsin. The protein was first
precipitated with cold acetone (-20 oC) and stored in a freezer (-20 oC) for 12 h. The supernatants
were discarded after centrifugation @150,000 g for 20 min. The resulting protein pellet was
denatured with 10 μL of 8 M urea, followed by dilution in 50 mM Tris-HCl buffer (pH 8.0) until
the urea concentration was less than 1 M. Trypsin was then added for digestion to a final proteaseto-protein ratio of 1:20 (w/w) at 37 °C for 12 h. Finally, 1 μL of pure FA was added to stop the
digestion.
3.2.4. Mass Analysis
For intact-protein analysis, mass spectra of the modified protein were taken with a Bruker Maxis
Q-TOF mass spectrometer. For each run, ~40 pmol of protein sample was passed over a custombuilt platform where the protein was captured by a C8 trap column and desalted at 200 uL/min of
H2O containing 0.1% trifluoracetic acid for 3 min. After the on-line desalting, the protein was
eluted with a 7 min gradient of 5% to 80% acetonitrile in 0.1% formic acid at a flow rate of 200
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uL/min. After the digestion, an aliquot of 5 μL tryptic peptides was loaded onto a custom-built
silica capillary column packed with C18 reversed-phase material. The HPLC gradient was
described as follows: from 2.5% solvent B (80% acetonitrile, 0.1% formic acid) to 18.5% solvent
B over 30 mins, then increased to 50% solvent B over 30 mins and subsequently jumped to 98%
solvent B over 2 mins and wash the column for 6 min, followed by a 12 min re-equilibration step.
A Q Exactive Plus hybrid quadrupole orbitrap mass spectrometer coupled with a Nanospray Flex
ion source (Thermo Fisher, Santa Clara, CA) was utilized for MS analyses. The instrumental
parameters were as follows: spray voltage of 2.5 kV; capillary temperature of 250 °C. The Q
Exactive Plus was operated in the data-dependent acquisition mode. Mass spectra were acquired
in the orbitrap (m/z 400−1600) with a mass resolving power of 70 000 at m/z 400 for MS1 and 17
500 at m/z 17 500 for MS/MS. The twenty most abundant ions were selected for higher energy
collisional dissociation at an automatic gain control (AGC) target of 500,000. Ions previously
selected for MS/MS were dynamically excluded for 3s.
3.2.5. Data analysis
The protein mass spectra were deconvoluted by PMI-intact whereby the spectra were processed
with peak sharpening functions, setting 9 Da spread function width. The LC-MS/MS raw files
were imported into the Byonic™ Software (Protein Metrics, San Carlos, CA, USA) coupled with
an in-house database. Byonic™ processing of the LC-MS/MS data of the trypsin proteolyzed CF3modified samples showed 96-98% sequence coverage for triplicate determinations of apo and holo
myoglobin (Mb). A tolerance of 20 ppm precursor mass tolerance, 60 ppm fragment mass
tolerance, and CID/HCD fragmentation. Modification sites on the peptide were assigned from
product-ion (MS/MS) spectra.
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3.2.6. Circular dichroism
Myoglobin samples (Apo and Holo states, 0.25 mg/mL) were incubated with or without 20 mM
NaSO2CF3 in 1x PBS buffer. Circular dichroism (CD) spectra were measured at room temperature
over the wavelength range of 195-340 at 0.5 nm intervals by using a JASCOJ815CD spectrometer
(JASCO Analytical Instruments, Tokyo, Japan).
3.3. Results and discussion
3.3.1. A test of biocompatibility of Langlois' reagent in protein solution by CD

Figure 21. CD spectra of apomyolgobin samples. Native apomyoglobin is incubated with 20 mM Langlois' reagent
(red) and without reagent (black).
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Figure 22. CD spectra of holomyolgobin samples.Native holomyoglobin is incubated with 20 mM Langlois' reagent
(red) and without reagent (black).

Maintaining a protein native structure is a major concern in protein footprinting. To ensure fast
labeling, footprinting usually makes use of excess reagent that is the radical precursor. The
precursor may perturb the protein higher order structure and yield misleading conclusions about
protein structure. Various approaches can be employed to check the protein high-order structural
integrity: examples are CD,[23-24]

reaction kinetics for individual modification sites,[25]

modification pattern at the protein level,[26] and activity assays.[27] CD spectroscopy is the most
common check because it is sensitive to variations in protein secondary structure. In the
development of •CF3 labeling, we analyzed both holo and apo myoglobin incubated with Langlois'
reagent by CD (Figure 21 and Figure 22). No change occurred in the CD spectrum of myoglobin
with and without the Langlois reagent, and CD curves showing helical structure were observed for
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both samples. The result shows that no significant secondary structural change occurs when
myoglobin is incubated with 20 mM Langlois' reagent in steps prior to FPOP oxidation.
3.3.2. Putative mechanism for X-ray mediated radical trifluoromethylation
Our major objective is to test whether radical trifluoromethylation is compatible with the X-ray
synchrotron platform. We mixed the model protein with the Langlois reagent in PBS buffer
without any additional reagents (e.g., transition metals, peroxide). We fixed the concentration of
Langlois reagent at 20 mM because this concentration worked efficiently in radical generation
from previous results.[21] The synchrotron platform permits the x-ray exposure to be adjusted over
a wide range of times. Here, we labeled the model protein at four different exposure times (0, 25,
50, and 75 ms).
We previously investigated the formation of •CF3 in the presence of •OH by DFT calculations with
Gaussian 9.0 (Figure 12). The results indicate that sodium triflinate, the water-soluble •CF3
precursor that we utilize, is extremely reactive to •OH. Once •OH forms, it rapidly reacts with
sodium triflinate with a near-zero transition-state barrier, implying that •CF3 is applicable on the
synchrotron platform.
The key to generating •CF3 is the •OH, formed by radiolysis of water. Based on our DFT
calculation, •OH directly attacks sulfur from CF3SO2- to produce a highly unstable intermediate
that rapidly collapses to •CF3. Using DFT, we establish there is a negligible energy barrier (2.96
kJ/mol) between the intermediate and the reactant complex. The subsequent formation of •CF3 is
highly favorable energetically because the reaction proceeds without any significant transition
state. Given that we used a 2,000-fold excess of the Langlois reagent relative to the protein, the
•OH more readily react with the Langlois reagent than with the protein (Figure 23b). This design
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is effective because the CF3-modified protein is the dominate product. In a minor pathway (Figure
23c), •OH abstracts an H from the protein to produce a protein radical that either couples with •CF3
to provide CF3-substituted products or reacts with HO• or dissolved oxygen to generate oxygenincorporated products. The small fraction of oxidized product could also be attributed to rapid
oxidation of methionine by •OH. From our bottom-up analysis at the residue level, we found
methionine is very sensitive to •OH but is silent to •CF3 labeling.

Figure 23. Putative mechanism for X-ray-mediated radical trifluoromethylation for protein footprinting.

3.3.3. Intact mass analysis of modified protein
MS analysis of the intact protein identifies the expected mass shift (+68 Da) corresponding to CF3
substitution of one hydrogen (Figure 24a) and demonstrates extensive labeling. •OH is produced
uniformly throughout the solution giving •CF3 ready access to the protein surface. With only 25
ms x-ray exposure, apo-Mb was modified by •CF3 up to at least three times (the resulting peaks
showing modification are resolved by MS, Figure 24a, middle). Notably, the deconvoluted
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spectra indicate a different footprinting pattern between the apo and holo states of the Mb. For
holo-Mb (Figure 24a, front), the most abundant modified protein contains one CF3 modification,
whereas for apo-Mb, we see a higher level of trifluoromethylation including mono, di, and tri CF3modified protein. This result is expected, because the apo state is less structured and has more
surface area. In addition to CF3 modification, we also observe a mass shift (+32 Da) corresponding
to di-oxidation. This signal comes at least in part because di-oxidation was seen in the control
sample without x-ray irradiation.

Figure 24. The analysis of •CF3 reactivities at synchrotron platform. The deconvoluted mass spectra. The mass spectra
for CF3-modified holo-myoglobin (front) and apo-myoglobin (middle) with 25 ms x-ray irradiation. The control
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experiment shows no CF3 modification on apo-myoglobin (back) with 0s x-ray irradiation. One pentagram represent
for one trifluoromethylation (+68), and one circle for one di-oxidation (+32).

3.3.3. The comparison of chemical reactivities between •CF3 and •OH
Having demonstrated trifluoromethylation on the synchrotron platform, we next examined, using
the synchrotron, how the •CF3 chemistry complements the •OH footprinting by modifying the
protein by •OH or •CF3 in independent experiments. The modified sites were identified using a
canonical proteomics strategy. The modification sites are displayed on a Venn diagram that reveals
unique and common modifications in each dataset (Figure 24b). The product-ion spectra aided by
extracted ion chromatograms (EIC) show modifications of 31 of a total of 153 total residues in Mb
by •OH and •CF3, giving 20% (31/153) reactivity coverage. Notably, •CF3 modifies nine residues
(in blue) that are silent to •OH. On the other hand, 13 AAs (in yellow) are modified by •OH, but
they are unreactive with •CF3. Both •CF3 and •OH can modify AAs containing aromatic side chains
(e.g., His, Trp) and aliphatic side chains (e.g., Leu, Val). Noteworthy is that •CF3 modifies normally
inert Ala, as confirmed by EIC (Figure 24c) and MS/MS (Figure 24d) . The modification of this
Ala is absent in •OH labeling and was not seen in our previous radical trifluoromethylation.[21] We
attribute this reactivity to the lower density of H2O2 compared to H2O ( 55 M water Vs 20 mM
H2O2) in solution. Overall, the desirable property of footprinting is to produce many high-quality
modifications at surface residues. A single platform that enables two chemistries improves
reactivity coverage and facilitates comparison. Therefore, trifluoromethylation is a true
complement to hydroxylation.
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Figure 25. Comparison of •CF3 and •OH chemical reactivities.(a) EIC for peptide 119-133 extracted from the 75 ms
exposure of holo-myoglobin in the CF3 radical protein footprinting experiment. (b) EIC for peptide 64-77 taken from
the 50 ms exposure of holo-myoglobin. EIC peaks for the unmodified (blue), hydroxyl-radical modified (orange),
CF3-radical labeled (red), and di-modified (green) peptides confirmed via MS/MS are labeled.
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We then examined the AA residue reactivity by quantifying the modifications at the residual level
when modified isomers were resolved by LC. One representative EIC for CF 3-modified peptide
119-133 (75 ms x-ray exposure) (Figure 25a) reveals a CF3-modifed species as the major product.
MS/MS analysis assigns the CF3-modification mainly on residues His119 and Phe123 and a minor
modification on Met 131. Considering that •OH is extremely sensitive to methionine, footprinting
with •OH is often dominated by reactions at methionine, muting the reactivity of other proximal
residues. In this case, trifluoromethylation occurs with different specificity, allowing other
residues (His 119 and Phe123) to be labeled. For another peptide 64-77 containing no methionine,
the reactivity pattern for the two radicals is also different (Figure 25b). The •CF3 reacts with His
64 whereas •OH mainly labels Val 68 and three Leu (Leu 69, Leu72, and Leu76).
Trifluoromethylation of Val 68, Leu72 and Leu 76 also occurs but less abundantly compared to
His 64. From their product-ion (MS/MS) spectra and the EIC, we conclude that •OH and •CF3
modifications occur concurrently via this platform for CF3-radical footprinting, suggesting that a
titration with CF3 can show the effects of both •CF3 and •OH modifications.
The literature indicates that •CF3 modification can be tuned to a narrow range of AAs if
stoichiometric amounts of •CF3 are used.[28-29] Those results in combination with ours suggest that
the •CF3 footprinting can be tuned or titrated by adjusting CF3 concentration. Given the tunable
reactivity of •CF3 and the dual footprinting of •CF3 and •OH on the synchrotron platform, our goal
of a complementary approach to achieve high coverage footprinting with a broadly reactive reagent
is closer to realization.
3.3.4. The evaluation of •CF3 as footprinter in synchrotron platform
Lastly, we evaluated whether •CF3 footprinting affords a protein footprint that is responsive to a
change in protein structure. The modification pattern responding to heme binding in Mb is
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reflected in both •CF3 and •OH footprinting (Figure 26). For AAs labeled by both •CF3 and •OH,
four AAs (i.e., H24, H36, H64, and F138) show similar trends of increased modifications for holoMb, whereas K77 maintains a constant rate between holo and apo Mb. On the other hand, V18
shows an opposite trend for the two radicals, where •CF3 labeling is greater for holo-Mb whereas
•OH labeling is less. The divergence at V18 is possibly due to the low reactivity of V18 (< 3%),
which may introduce artifacts. Overall, the outcome indicates the two reagents respond similarly
to changes in structure although they have different reactivities. This similarity is due in part to the
water solubility of the Langlois reagent, allowing a homogeneous production of the reactive
species in places where bulk water penetrates.
However, the modification extent increases upon binding to the heme. Our previous •CF3 and •OH
footprinting, and radical iodination show a single peptide region (peptide 80-96) that undergo
significantly different modification extents between apo and holo. [23,8] From a plot of the fraction
of unmodified peptide versus exposure time (Fig. 5a), we see a similar trend. [23,8] The results here
reveal that more residues surrounding the heme pocket undergo significantly different
modification extents in the apo vs. holo states (e.g., H64, V68 and F138).
Peptide 80-96 contains the ordered F-Helix in holo-Mb, but this helix is not formed for apo-Mb as
shown by NMR.[30] Top-down HDX/MS reveals this region exchanges faster in apo than in
hMb.[31] Although we observed the red color disappears for apo Mb, it is not clear that the F-helix
completely reverts to random coil after heme loss. The relatively higher CF3-modification level of
peptide 80-96 for apo suggests that the F-helix may undergo incomplete unfolding for apo under
neutral condition (Figure 26a). That interpretation is in line with findings by Konermann and
coworkers who found the F-helix is partially retained for apo-Mb.[32] The divergence requires
further investigation as the experiments are performed on different platforms with different batches
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of proteins. Nevertheless, the •CF3 clearly shows increased side-chain solvent accessibility in the
region of aMb that becomes the F helix for holo.

Figure 26. The comparison of X-ray-induced •CF3 and •OH at a residual level.Changes in the modification rates in
response to heme binding, for the rates of •CF3 modification (a) and the rates of •OH modification (c). Changes were
mapped on to the structure of holo-myoglobin (PDB: 1WLA) to identify regions with increased (red), decreased (blue),
or unchanged (white) rates of modification upon heme binding, for •CF3 modification (b) and •OH modification. (d)
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the fraction of unmodified peptide versus exposure time (Fig. 5a), we see a similar trend. [23,8] The results here reveal
that more residues surrounding the heme pocket undergo significantly different modification extents in the apo vs.
holo states (e.g., H64, V68 and F138).

To illustrate further their footprinting pattern in this region, we manually extracted its ion
chromatogram for peptide 80-96. Based on the MS/MS analysis, three His residues are labeled by
•CF3 as shown by the well resolved chromatography (Figure 26b). It’s known that the
chromatographic system could discriminate between molecules that differ by degree of
fluorination. As expected, the CF3-modified peptide retains longer time in stationary phase
compared to wildtype peptide. This behavior is correlated to the strong absorption of the
fluorinated compound on the adsorbent surface. However, we also observe good separation for
CF3-modified isomers that contains even identical number of fluorine atoms. We rationalize that
CF3-modified isomers could adapt different conformation, responding discriminately to LC. This
property can be exploited in the future to improve the LC resolution or enrich fluorine-containing
peptides in more complex biological samples.

Figure 27. The fraction of unmodified peptide versus exposure time at peptide 80-96.The EIC of peptide 80-96.
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3.4. Conclusion
we successfully extended a new reagent for synchrotron-based protein footprinting and showed its
complementarity to •OH labeling.

The LC-MS/MS analysis enables a comparison of the

footprinting patterns produced by these two reactive radicals and shows the reactivity of •CF 3
complements that of •OH, resulting in higher reactivity coverage. Even for the same peptide
regions, •CF3 exhibits different reactivities with AAs side chains. The new method enriches the
current synchrotron platform by taking advantage of the complementary reactivities of •CF3 and
•OH, which is the most widely used reagent for irreversible protein footprinting. The outcome also
suggests that the synchrotron platform is adaptable to other novel chemistries that may enhance
footprinting coverage, in this case by forming the reactive species with •OH. Further, direct protein
trifluoromethylation in the absence metal catalysis or peroxide addition has been achieved, for the
first time, with the synchrotron platform. Trifluoromethylation may also useful for protein
engineering because trifluoromethylated proteins keep their enzymatic ability; furthermore,
specific protein trifluoromethylation is tunable with appropriate dosimetry and adjustable labeling
timescales. In the future, we will investigate how to tune •CF3 reactivity and extend this novel
chemistry to other protein systems.
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Chapter IV: Fast Transmembrane Domain
Labeling of Integral Membrane Protein
Enhanced by Tip Sonication

The manuscript for chapter is in preparation : Ming Cheng, Weikai Li and Michael L. Gross et
al.“ Fast Transmembrane Domain Labeling of Integral Membrane Protein Enhanced by Tip
Sonication”.
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4.1 Abstract
We describe a laser-mediated, free-radical footprinting method for integral membrane proteins
(IMP) that extends significantly the “fast photochemical oxidation of proteins” (FPOP) platform.
This new approach exploits the highly hydrophobic nature of perfluoroalkyl iodides together with
tip sonication to ensure efficient transmembrane domain (TM) labeling. The chemistry yields 100%
reactivity coverage for tyrosine, and fast, complete IMP labeling. The resulting modifications,
which are resistant to hydrolysis, are amenable for tandem mass spectrometric bottom-up analysis.
4.2. Introduction
Integral membrane proteins (IMPs) play an essential role in numerous cellular functions (e.g.,
signaling, transport, and catalysis). They represent ∼30% of the open reading frames of many
genomes, and an increasing number of them are important drug targets.[1] Despite their importance,
obtaining high-order structural information for IMPs is chanllenging, and less than 1% of all solved
protein crystal structures are IMPs and only structures of ~100 human IMPs are known to date.[23]

Furthermore, common high-resolution structural techniques (i.e., X-ray crystallography, Cryo-

EM) often fail to interrogate protein dynamics that is crucial for the function of IMPs.[4]
Mass spectrometry (MS) has emerged as an integrative method in IMPs structural biology. Its
advantage over other biophysical methods (e.g., circular dichroism, X-ray crystallography, CryoEM or NMR) is its readout of a broad range of structural information, including stoichiometry,
interaction sites, conformation, and dynamics.[5] Although MS-based structural proteomics is
growing rapidly, structural analysis by IMP has also been slow, and its outputs are underrepresented compared to that of their souble counterparts.[6] Key developments for MS methods
are advances in instrumentation,[7-10] appropriate methodologies for protein solubilization
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including native vesicles, lipid nano- and picodiscs[11-12] and MS-compatible surfactants, and
arguably the most important in-solution footprinting methods for IMPs.[13]
For soluble proteins, “footprinting” characterizes their structure by using hydrophilic reagents to
label protein surface to afford a measure of solvent accessibility of the backbone or side chains in
aqueous solution. This principle rightly determines the logic of footprinter as they target watersoluble proteins. On the other hand, IMPs contain a large hydrophobic transmembrane (TM)
surface and are buried in lipid bilayer, thus requiring a hydrophobic footprinting reagent that works
in a TM region.

Figure 28. Water molecules observed in the crystal structures of family A GPCRs.Structural superpositioning of the
Cα chains reveals that many of the ordered waters found in available high-resolution GPCR crystal structures are
colocalized. (A) (B) (C) Zoom-in spectra for positions of the waters ,shown as spheres, from the structure of
rhodopsins. Figure 26 is cited from reference with permission. [14]
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Figure 29. FPOP maps the topology of intrinsic membrane proteins in a nanodisc. Outer membrane regions are
more heavily footprinted by •OH whereas the regions spanning the lipid bilayer remain inert to the labeling. The
figure is cited from reference with permission. [15]

Several strategies for IMP irreversible footprinting have been exploited. For examples, in fast
photochemical oxidation of protein (FPOP), Konermann

[16]

and Gross

[15]

found that ⋅OH

(generated from photolysis of H2O2) selectively labels outer membranes of IMP in nanodisks and
vesicles. Radford and coworkers[17] identified that the use of amphipol A8-35 reduces ⋅OH labeling
extent for outer membrane protein OmpT and enhances the labeling efficiency for the lower
boundary of TM. Using X-ray mediated hydroxyl radical footprinting (HRFP), Chance also
defined the outer membrane region of IMPs.[18] Because X-rays from a synchrotron can directly
ionize internal water molecules, this platform leads to footprinting of hydrophobic TMs where
ordered water is tightly bound.[19] Using another reagent, a diradical or carbene from an
amphipathic source, Oldham, Moses and coworkers effectively labelled the TM of OmpF.[20] Aside
from these broadly reactive reagents, relatively slow, residue-specific reagents (e.g., DEPC,[21]
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EDC,[22] NEM[23-28]) have specific applications for IMPs and membrane-associated proteins. They
rely on solvent exposure of particular residues (e.g. Cys or His) and modify hydrophilic protein
surfaces either in solution or on the interface boundary.

Figure 30. The common reagents for membrane protein footprinting. (a) The predicted LogP for commonly used
footprinter. (b) The enhanced partition of PFIPI into micelle with tip sonication.

Owing to amphipathic nature of IMP, we rationalized that reagents with high partition coefficient
(P) are perhaps well or even better suited for TM labeling. We opted to perfluoroisopropyl iodide
(PFIPI), due to its high LogP, small size and being amenable to tunable chemistry through 248 nm
laser photolysis in FPOP. In specific, our design relied on two characteristically chemical
properties of PFIPI: first, TM is buried in the sea of C-H bonds from lipid or detergent tail. C-F
bonds are known to mimic C-H bonds because a F replacement for hydrogen won’t dramatically
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affect the overall molecular size or hindranrance.[29] Driven by “Like dissolves like”, it would
ensure the efficient incorporation of PFIPI into the bilayer without structural perturbation. Second,
PFIPI chemistry is fast and controllable. PFIPI is stable in dark while the C-I bond in PFIPI can
be dissociated within pico s timescale[30] under 248 nm laser and simultaneously generate two
reactive radicals for footprinting. Also, when irradiated with 248 nm laser, the perfluoro alkyl
iodine could reach almost 1.0 quantum yields of prouduction of reactive iodine species, which is
much higher than its alkyl iodine counterpart.[31] Further, the laser could act as a “switch” to turn
on or turn off footprinting and label protein in a pulsed manner.
Here we describe, as a proof-of-principle, a new method for TM labeling that utilizes a
hydrophobic reagent (PFIPI) as a footprinter, which is the most hydrophobic reagent applied for
protein footprinting to date (Figure 28a). Our objective is to demonstrate that hydrophobic PFIPI
is amenable for native protein strucutrure in lipid enviroment (e.g., not denaturing or perturbing
the protein or the lipid bilayer). Further, we increase the effectiveness of the method by tip
sonication, which significantly enhances PFIPI partition into the lipid bilayer.
4.3. Materials and methods
4.3.1. General information
Unless otherwise noted, all materials were used as received from commercial sources without
further purification. Protected tyrosine ( N-Acetyl-L-tyrosine ethyl ester, 97% purity ) and
perfluoroisopropyl iodide (PFIPI, 97% purity) are purchased from Alfa Aesar. Tris base ( >99.9%
purity), urea, water, acetonitrile, formic acid were obtained from Sigma-Aldrich Chemical
Company (St. Louis, MO, USA). n-Dodecyl-β-D-Maltopyranoside (DDM) was obtained from
anatrace. Membrane protein VKOR membrane protein was provided by Dr. Weikai Li from DBBS
at Washington University in St. Louis. Chymotrypsin and TECP-HCl were purchased from
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Thermo Fisher Scientific. 130 Watt ultrasonic processor ( Model No. VCX 1300 was used for tip
sonication. The concentrations of all the protein stock solutions were determined by UV absorption
using Thermo Scientific™ NanoDrop™.
4.3.2. Preparation of sample solution
4.3.2.1. Protected tyrosine sample preparation
Protected tyrosine (PT, 295.93 g/mol) was dissolved in MeCN/H2O ( v/v, 1:1) to make 200 uM
stock solution. For each run, PT samples were diluted with MeCN/H2O, and PFIPI was added to
make a solution of 100 μM PT with different equivelents of PFIPI in 50 µL volume.
4.3.2.2. Membrane Protein VKOR Sample Preparation
3 mg DDM (Anatrace D310) was dissolved in 10 g Tris buffer (200 mM, pH=7.5). The resulting
0.03% DDM Tris buffer solution was sonicated to make sufficient mix . VKOR stock solution (1
mM) was diluted in 0.03% DDM Tris buffer to make a VKOR solution (100 μM).
4.3.3. Tip sonication
Eppendorf tube containing 50 uL samples is sonicated in ice bath on an adjustable platform. The
probe was immersed , and platform was adjusted to make the end of probe 1/2-way down into the
solution. Ensure probe tip does not contact the bottom of the tube. Switch power on. For sonication
set-up: set amplitude to 20%, while each duty cycle contain 2s sonication, followed by 10s off for
resting.

4.3.4. The optimization of condition

81

Table 4. The conditions for sample preparation
Sample ID

Sonication Cycles

PFIPI reagent volume

FPOP

2µL -0cycles

0 cycles

2 µL

Yes

5µL L-0cycles

0 cycles

5 µL

Yes

2µL -4cycles

4 cycles

2 µL

Yes

2µL -8cycles

8 cycles

2 µL

Yes

2µL -12cycles

12 cycles

2 µL

Yes

Control

4 cycles

2 µL

No

Prior to FPOP labeling, the sample was prepared under different conditions. Specifically, we test
conditions with two PFIPI concentration (2 µL Vs 5 µL). The addition of 2 uL PFIPI into 48 uL
VKOR sample solution results in 4% (v/v) of PFIPI in the solution. We also screen the number of
sonication cycles while keep the PFIPI concentration constant at 4%. For control experiment, 2
uL PFIPI was added with 4 cycles of sonication but without FPOP laser irradiation.
4.3.5. Radical trifluoromethylation of protein in FPOP system
The 50 μL sample in syringe was carried with syringe pump. A flow rate (20.5 μL/min) was
calculated on the basis of laser spot width (2.4 mm) and laser frequency (7.2 Hz) to ensure 20%
exclusion volume. The sample solution was irradiated by a 248 nm KrF excimer laser (15mJ/pulse,
GAM Laser Inc., Orlando, FL) when passed through capillary window (Fig.4). The flow rate was
adjusted with syringe pump and the laser pulse frequency was controlled by an external pulse
generator (B&K Precision, Yorba Linda, CA). Presumably every portion of sample solution are
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only subjected to one laser shot. All samples were collected in vials containing 10 μL of 500 nM
catalase and 7 mM methionine, protecting protein from further oxidation by H2O2.
4.3.6. Proteolysis
After labeling, duplicate protein samples were digested by chymotrypsin. Briefly, the protein was
precipitated with pre-cold acetone (-20 oC) and stored in freezer for 12 hours. The supernatants
were discarded after centrifuge. The resulting protein pellet were denatured with 10 μL 8M urea
and then reduced by TCEP-HCl (0.5 μL,50 mM) at 37 oC for 30 min, followed by cysteine
alkylation with iodoacetamide (0.5 μL,100 mM) at room temperature and in the dark for 30 min.
The denatured proteins were digested by chymotrypsin with a final protease to protein ratio of 1:20
to 1:100 (w/w) at 37 °C for 12 h. Finally, 1 μL formic acid was added to stop the digestion.
4.3.7. Mass analysis
After the digestion, an aliquot (5 μL) of sample was loaded onto a custom-built silica capillary
column packed with C18 reversed-phase material (Waters Symmetry ,5 μm, 100 Å, 75 μm ×30
cm;). The HPLC gradient for myoglobin/apomyoglobin/beta-lactoglobulin was set as follows:
from 2.5 % Solvent B (80 % acetonitrile,0.1 % formic acid) to 40 % Solvent B over 50 min, then
jumped to 98% Solvent B over 6 min at a flow rate of 0.45 μL/min followed by a 10 min reequilibration step. The HPLC gradient for VKOR protein was set as follows: from 2.5 % Solvent
B (80 % acetonitrile,0.1 % formic acid) to 40 % Solvent B over 30 min, then increased to 65%
Solvent B over 20 min, finally ramped to 98 % over 6 min followed by a 10 min re-equilibration
step. A Q Exactive Plus hybrid quadrupole orbitrap mass spectrometer coupled with a Nanospray
Flex ion source (Thermo Fisher, Santa Clara, CA) was utilized for MS analyses. The instrumental
parameters were set as follows: spray voltage of 2.5 kV; capillary temperature of 250 °C; The Q
Exactive Plus was operated in data-dependent mode. MS spectra were acquired in the orbitrap
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(m/z 300−1600) with a resolution of 70 000 at m/z 400 for MS1 and 17 500 at m/z 17 500 for
MS/MS. The five most intense ions were selected for HCD fragmentation at an automatic gain
control (AGC) target of 200 000. Previously selected ions were dynamically excluded for 8 s.
4.3.8. Data analysis
LC-MS/MS raw files were imported into the Byonic™ Software (Protein Metrics, San Carlos, CA,
USA) coupled with an in-house database. Byonic™ processing of the LC-MS/MS data of the
trypsin-proteolyzed CF3- modified samples showed 96% sequence coverage for the triplicate Holo
/Apo myoglobin complexes. We chose 10 ppm precursor mass tolerance, 60 ppm fragment mass
tolerance, and CID/HCD fragmentation. The accuracy of mass assignment on each fragment ions
are double-checked with custom program Thermo Xcalibur. We calculated the ppm for all crucial
fragments ions that assigns CF3 modifications on 18 different amino acids. The ppm values of each
crucial fragment ions were added at the legend of each mass spectra. Modification fractions for
certain peptides were interrogated with Byologic™ software (Protein Metrics, San Carlos, CA,
USA) and double-checked with custom program Thermo Xcalibur. Modification sites on the
peptide were assigned on the basis of product-ion spectra (MS/MS data). The assignments were
further validated by manual inspection of their accurate mass and product-ion spectra. Extracted
ion chromatograms (XIC) ratio are calculated based on the following equation:
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4.4. Results and discussion
4.4.1. The test of PFIPI reactivities with protected tyrosine

Figure 31. PFIPI reacting with protected tyrosine. The mono- and di-iodinated product are detected by MS, while
no perfluoroalkylated product is found.

Figure 32. The iodinated ratio for tyrosin labeling by PFIPI.The modified ratio is measured based on EIC of
peptide species. The kinetic curves represent the mono-modified (in black) and di-modified ( in red).

We first tested the PFIPI reactivity with protected amino acids. We choose protected tyrosine (PT)
because tyrosine was well-demonstrated to react with both perfluoro alkyl and iodine radical.[32-33]
The PT was mixed with different equivalents of PFIPI in solvent (acetonitrile/water=1:1 (v/v)),
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followed by 248 nm laser irradiation (Figure 31). We observe mono-iodinated and di-iodinated
PT, whereas no perfluoroalkylated PT was detected by MS. Strikingly, 50 equivalents PFIPI even
modified PT up to 22% within µs time scale, suggesting PFIPI is an appropriate agent for fast
footprinting. Figure 32 compares fraction conversion of the PT to product with increased
concentration of PFIPI. The footprinting reaction proceeds in a steady manner and ultimately
provides the highest conversion (average 70% coversion to mono-iodinated PT, and 11% to diidodinated PT), albeit with the requirement for high doseage of agent ( x103 equiv.).
4.4.2. The ue of tip sonication to facilitate reagent partition

Figure 33. Pulse of sonication.One sonication cycle (left) includes 1s sonication with 20% amplitude followed by 10s
rest. Each cycle lasts 11s. VKOR membrane protein in 0.02% DDM Tris buffer (100 mM) is mixed with reagent in
an Eppendorf tube. The probe is dipped into solution which is sonicated by probe for different cycles under ice bath
(right).
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Figure 34. Chymotryptic sequence coverage.Chymotryptic digestion yield ~97% sequencing coverage for VKOR
under different labeling conditions. The VKOR labeld under different conditions yielded different extent of
modification. Based on their coverage, the modification with different extent don’t undermine the VKOR proteolysis
efficiency by chymotrypsin. An deep analysis of impact on VKOR digestion at bottom-up level are described in the
following section.

Using vitamin K epoxide reductase (VKOR) as a model, we next determined whether PFIPI could
diffuse into micelles and label the TM region. We used a pulsed sonication to reduce heating the
sample during sonication. For each cycle, we turned on the sonicator for 1 s, then off for 10 s
(Figure 33). The site of the modification was determined by LC-MS/MS analysis after digestion
with chymotrypsin, which, notably, gave ~97% sequencing coverage for VKOR. Figure 34 shows
the yield of chymotryptic peptides containing iodine substitution as a function of several
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experimental designs). We found PFIPI labeled the TM region (from Tyr4 to Tyr 178) most
efficiently under condition of “2µL-4 cycles” (2 uL PFIPI for 4 cycles sonication). This optimized
condition even yielded higher-level modification compared to 5µL-0 cycles, supporting that tip
sonication is a key factor determining successful partitioning of the PFIPI to the nonaqueous phase
(Figure 35). Because modification efficiency does not improve with increasing cycles (Figure 36),
4 cycles of sonication is adequate to transport reagents into micelle probably owing to direct
submersion of the probe.

Figure 35. Proportion of peptides identified in each of three different experiment conditions.We observed wildtype
(black), mono-iodination (blue) and di-iodination (orange) peptide species. Bar (left) represents for 2uL-0cycle, bar
(middle) for 5uL-0cycles,and bar (right) for 2uL-4cycles. We found 2 uL-4cycles labeled most efficiently compared
to 2uL-0cycle and 5uL-0cycles, supporting that tip sonication enhance the reagent distribution.
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Figure 36. We compared the modification pattern with increasing sonication cycles.Bar (left) represents for 2uL4cycle, bar (middle) for 2uL-8cycles,and bar (right) for 2uL-12cycles. Labeling efficacy doesn’t increase significantly
with more sonication cycles, suggesting that 4 cycles of sonication is sufficient to distribute the reagents in solution.

4.4.3. The labeled residues mapping onto the crystal structure
With these results, we highlight the labeling sites identified by LC-MS/MS analysis (Figure 37).
The data show that labeling is very sensitive to residues containing aromatic rings (i.e. Tyr, His,
Trp). Based on mass analysis, we identified a total of 12 amino acids iodinated in TM, including
eight Tyrs, two Trp and two His. Notably, all Tyrs in TM were labeled with different extent, giving
100% reactivity coverage to Tyr labeling. This behavior sharply contrasts with our previous
studies[34] when we used Langlois reagent as footprinter, a hydrophilic reagent in the form of
sodium salt that are unable to label TM. PFIPI, however, also label residues in outer membrane.
We hypothesize that the PFIPI could potentially attach on the protein surface where fluorine may
act as a weak hydrogen bonding acceptor.[35] The result is in line with previous studies by Oldham
group who also observe hydrophilic residues in solution are labeled with amphipathic agent.[20]
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Figure 37. Labeled residues mapping in crystal structure.PFIPI is extremely reactive to tyrosine. All tyrosines are
modified with different extent. We also observed Trp and His were modified.

4.4.4. The deep analysis for iodination impact on protein digestion
Typically, when performing proteomics analysis, one has to consider that modifications ( e.g.
post-translational modifications, PTMs) are likely to have an impact on proteolytic efficiency.
These modifications include phosphorylation, glycosylation, ubiquitination, nitrosylation,
methylation, acetylation, lipidation and proteolysis and influence almost all aspects of normal cell
biology and pathogenesis. For instance, digestion by LysC or LysN are hampered by acetylation
that commonly occurs in almost all eukaryotic proteins. This again might result in the generation
of peptides unamenable to MS analysis. Reduced proteolytic activity has also been reported when
the PTM (e.g., phosphorylation and O-GlcNAc) occurs on residues in the proximity of the
cleavable site, because of steric and/or electrostatic hindrance.[36-38]
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Because tyrosine residues are heavily iodinated, we next examine whether iodinated tyrosine will
compromise their preference for chymotryptic digestion. Although effect of iodination on
digestion is not found, numerous PTM-based proteomics analysis reveals that modification on
cleavage site or proximal position reduce proteolytic efficiency. We analyzed the cleavage
frequency using nonspecific search setting, which enable us to calculate the number of unique
peptides on all potentially cleavage residues. The chymotrypsin is turely nonspecific enzyme
because it cleaved at the C-terminal of 18 different amino acids (AAs) (Figure 38). The prefered
cleavage sites occur on Tyr,Lue, Phe and Met, which have higher cleavage frequency than amino
acid composition. This resut is consistent with previous studies from Heck group who also
observed this high nonspecificity.[39] In comparison between the wildtype and iodinated VKOR,
we found the iodination don’t alter their digestion pattern. On the contrary, we observed higher
cleavage frequency occur on iodniated Tyr. This phenomene are attributed to the increased number
of unique Tyr-containing peptides from iodination.
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Figure 38. Comparison of digestion pattern between wildtype and iodinated VKOR.Wildtype VKOR (top panel) and
iodinated form (bottom panel) of VKOR. The green bar represent the amino acids composition in VKOR. The amino
acids composition calculation is based on the sequence of VKOR (3KP9) with cysteine 209 being mutated into alanine.
For example, VKOR contains 285 amino acids in total, with 14 tyrosine. So the composition of tyrosin is equal to
14/285=4.9%. Unique C-terminal flanking regions of the identified peptides were used for the calculation of the
cleavage frequencies at the cleavage site. The overall digestion pattern is similar between wildtype and iodinated form
of VKOR, supporting that idodination don’t have significant impact on chymotrypic diegetion.
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Figure 39. Representative LC-MS/MS spectra.Peptide 197-204 in +2 charge state. (a) EIC for peptide. The
incooperation of iodine increase the eluted time at reversed HPLC. (b) MS/MS spectra for mono-iodinated peptide
197-204, and (c) for di-iodinated one. The chmotrypsin readily cleave at the C-term side of Tyr bearing iodination.
We observe iodinated Tyr in form of product Y ion and immonium ion.
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Taking advantage of tandem mass analysis, we confirm the modification on AAs sites. For
example, the LC-MS/MS analysis for peptide 197-204 ( Figure 39) vitally reveal three key aspects:
1) the fact that iodinated tyrosine is apparently benign with respect to chymotryptic protelysis, as
shown in Figure 39b and Figure 39c, mono-iodianted or even di-iodinated trysoine can be
enzymatically cleaved and measured by MS. 2) the iodination on tyrosine is stable and tolerant of
CID fragmentation since we not only observe mono- or di- iodinated tyrosine in product Y ion,
but also detected them in the form of immonium ion. These signature ions further confirm the
modification on tyrosine , which offer a wealth of information for peptide identification. 3) Last
but not least, the LC-peak shift to longer retention times in reversed-phase HPLC (Figure 39a),
with an increased number of iodine at Tyr204. This behavior is consistent with our previous studies
on CF3 modification,[34] whereas contrast with the hydrophilic reagents of other footprinting
methods (e.g OH labeling). It’s well-known that chymotrypsin prefers to cleave peptide bonds on
the C-termial side of the large hydrophobic amino acids (e.g. Trp, Tyr, or Phe). Idodiantion
substitution maintain or even increase the hydrophobic nature of Tyr or Trp. This observation
provide us clue to understand why incooperation of iodine doesn’t alter the chymotryptic digestion.
4.5. Conclusion
In conclusion, we developed a novel footprinting method for an efficient TM labeling, as
demonstrated in footprinting integral membrane protein VKOR in DDM. In contrast to previous
footprinting methods, the PFIPI reagent is the most hydrophobic reagent applied for protein
footprinting to date. The application of tip sonication significantly enhances the reagent partiion
into lipid enviorment and without protein strutural pertubation.
The strategic merits of this approach are (1) PFIPI is a small reagent, mimicing the hydrophobic
tails of the lipids and detergents that are essential for the TM native environment. The bioactivity
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assay indicates that the incorperation of reagent does not significantly perturb the native VKOR
structure. The structure of PFIPI allows it to diffuse into a lipid enviroment, consistent with “like
dissolves like“ principles. (2) This novel chemistry combined with OH lableing can be enabled by
a 248 nm laser as part of the standard FPOP platform, giving an approach that is highly
complementary to hydroxyl radical footprinting of hydrophilic regions of proteins. (3) The
idodinated modification is compatible with bottom-up MS/MS analysis, as it is resistant to
hydrolysis, non perturbing for protelysis, and amenable to tandem mass analysis. (4) The
dissociation of the C-I bond is rapid (0.5-3 x 10-13 s), making it suitable for fast footprinting. The
quantum yield for homolysis of perfluoroakyl iodide bond is nearly 1.0 for 248 nm excitation. This
last feature is consistent with our observation that rapid iodination of Tyr in TM regions requires
only 50 equivalents of PFIPI, one pulse of the laser and yet the chemistry is complete within ~

s

timescale.
We note that PFIPI doesn’t selectively label TM, persumely due to pre-attachement on protein
surface with weak hydrogen bond. We observe only iodination even though PFIPI photolyzes to
generate both •I and •C3F7. The modification by •I only reduces the complexity for footprinting
and data interpretation, with a small risk of sacrificing coverage.
The outcome of this method development open a new area of application of hydrophobic reagent
for protein footprintinger. We believe that the concept presented herein represents a useful
additional way to achieve high coverage footprinting for membrane protein. The investigation of
the mechanism and generality of method is underway.
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5.1. Abstract
Integral membrane proteins (IMPs), constituting 50–60% of drug targets, play important roles in
many biological processes. IMPs, however, are under-represented in conventional bottom-up
proteomic analysis, which generally favors soluble, abundant and easy-to-digest proteins. Despite
tremendous progress in classical membrane proteomics, most studies focus on protein discovery
at a proteome sacle. There is also a need, however, for a targeted approach for a specific membrane
protein or membrane protein complex. Structural proteomic based tools (e.g., HDX, protein
footprinting) typically rely on targeted approches to generate sutitable peptides for structural
chracaterization. Here, we describe an investigation of several conditions using different
combinations of protease and additives to optimize the coverage of IMPs digestion. We applied
filter-aided sample preparation (FASP) that can conveniently and effectively remove detergent
prior to MS analysis. The optimized conditions generally yield >90% sequence coverage. We also
choose an amphipathic IMP, vitamin K epoxide reductase (VKOR), as a model. This protein
consists of an extramembrane domain (a hydrophilic lid) and a transmembrane domain (TMs), and
its choice enables us to compare directly digestion patterns from those two domains within a single
protein and under different proteolytic conditions. Aided with MS retention peptide calibration
and hydrophobic factor (HF) simulation, we identify a “sweet spot” suitable for detecting peptides
from transmembranes. Our findings show the “split personalities” of IMPs in bottom-up analysis.
The protocols here are suitable for targeted IMP analysis, especially for structural proteomics.
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5.2. Introduction
Integral membrane proteins (IMPs) are classes of important proteins involved in numerous
biological and pharmacological functions, including intercellular communication, cellular
development, signal transduction, cell migration, and drug resistance. Although IMPs only make
up ~30% of the human proteome, IMPs constitute nearly 60% of current drug targets.[1-2] Of that,
GPCRs are most prevalent, followed by ion channels and receptors. Membrane-associated
enzymes, solute carriers and transporters are also important drug targets (Figure 40). Therefore,
advances in analytical technologies to characterize better and understand IMPs are highly desired.

Figure 40. Human membrane proteins as drug targets.Human membrane proteins of different classes represent about
60% of all protein drug targets: GPCRs are most prevalent, followed by ion channels and receptors. (b) Trends in the
indications of approved GPCR-targeted drugs and agents in clinical trials. The colour gradient from red to green
highlights the most established and novel indications, calculated as the ratio of approved and in‑trial agents,
respectively. Figure 36 was adapted from reference (Fig.40a)[1] and reference (Fig.40b)[3].
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Mass spectrometry (MS) based proteomics is emerging as a powerful tool to characterize highorder structure of proteins in addition to their their primary structure, post-translational
modifications, sequence variants.[4-5] MS analysis for IMPs, however, still is a challenge owing to
the highly hydrophobic nature, resulting in poor solubility in aqueous buffer, low ionization
efficiency, lack of tryptic residues to aid digestion, and poor sample recover owing to precipitation
and aggregation.[6-8]

Table 5. The most common additives in membrane proteomics, adapted from reference.[9]
Additives

Advantages

Disadvantages

Detergent
Sodium dodecyl
sulfate (SDS).

Efficiently solubilizes and denatures IMP; Can
be removed by using the FASP procedure.

Proteases do not tolerate > 0.1%
SDS; SDS impairs LC-MS;
Removal procedures cause loss of
sample.

Sodium dodecyl
cholate (SDC)

Trypsin tolerates 5% SDC; Can be removed by
phase transfer or acid precipitation.

Lower solubilizing and denaturing
ability compared to SDS

Acid-labile
surfactants

Rapid detergent removal by acid cleavage

Expensive; loss of hydrophobic
peptides after acid cleavage and
precipitation (RapiGest)

Can be used to solubilize IMPs; Trypsin remains
partially active in 60% methanol (or 25% TFE);
Easy evaporation prior to LC.

Trypsin activity and specificity are
severely lowered in 60% methanol.

Formic acid

Effectively solubilizes membranes, hydrophobic
proteins and peptides; Compatible with chemical
cleavage using cyanogen bromide.

Incompatible with most proteases.;
May cause formylation and
hydrolysis of peptides.

Chaotropes

Urea denatures extra-membrane parts of IMPs in
combination with proteases (Lys-C,Glu-C);
Efficient removal of both guanidine and urea
prior to LC/MS using common desalting
methods.

Does not solubilize IMPs;
Incompatible with trypsin at high
concentrations; urea may cause
protein modifications.

Organic solvents
Methanol,
Trifluoroethanol

Urea, guanidine
hydrochloride
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To overcome these challenges, various methods have been developed to improve the efficacy of
IMPs bottom-up analysis. The methods include new approaches in sample preparation (e.g.,
protein solubilization, separation and digestion) as well as refinement of the technology employed
for MS analysis.[10, 8] Specifically, chemical additives such as chaotropic reagents,[11] surfactant,[1216]

organic solvents,[17] and organic acids,[18] have been used to solubilize membrane proteins

(summarized in Table 5). Li and coworkers[19] described a microwave-assisted strategy to
physically enhance IMPs solubilization. For IMPs separation and enrichment, strategies like
density-gradient centrifugation,[20] glycan moieties-directed enrichment,[21] chemical labeling of
surface protein,[22-23] were employed for enrichment of IMPs, and they overcome challenges of
detecting low abundant IMPs. To improve proteolytic efficiency, Hettich and coworkers[24]
developed a multienzyme digestion strategy that uses sample filtration to recover undigested
proteins for consecutive proteolytic digestion. Li and cowokers developed a protocol to footprint
membrane proteins in live cells, followed by in-gel protein purication and digestion.[25] These
methods helped to reach nearly full proteome or sequene coverage.
Despite these extensive effects and significant improvement for dealing with the membrane
proteome, most proteomic studies aim to improve the IMPs discovery on a proteome scale; that is,
to increase the percentage or number of detected proteins, to improve the confidence of identified
peptides and post-translational modifications (PTM), and to increase the sequence coverage.
Although they are powerful to identify thousands of proteins qualitatively in cells or other
biological samples, there are still challenge to quantitate these IMPs. Further, for most experiments
in structure proteomics (e.g., protein footprinting, hydrogen deuterium exchange (HDX)), the
experiments are performed in vitro and with a single protein or protein complex. The accuracy of
stuctural readout relies on high-quality mass spectra from LC/MS/MS, suitable for accurately
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measuring and quantifying the amount of modified peptide from several states of protein, rather
than increasing the number of identified proteins, as is the case for proteomics. In this scenario,
enzymatic digestion that produce peptides with suitable size or m/z, sufficient abundance, and
near-full sequence coverage for routine mass analysis is critical for success in strucutrual
proteomic studies.
Our previous studies with membrane protein footprinting imply that membrane protein behavior
is different from that of soluble protein. Although we obtained 85% coverage from tryptic
digestion, a large peptide in TMs was still not covered by our routine protocol.[26] Also, we
observed the hydrophobic peptides from TMs are retained in reversed-phase LC with much longer
time and elute as wide peaks.
Herein, we report a protocol for efficient IMP digestion. Specifically, we applied the FASP
technique and showed it to be adequate to remove detergent or lipids prior to mass analysis. We
inverstigated several conditions (e.g., protease, additives) to improve the sequencing coverage and
LC resolution. We found that certain conditions are not suitable for structural proteomic studies
even though they can yield nearly full coverage. Noteworthy is that we choose an amphipathic
protein, VKOR membrane protein, as a model that contain a hydrophilic extramembrane domain
and a hydrophobic transmembrane domain. This model enables us to compare directly the dynamic
range (e.g., peptide intensity, number of unique peptides) for two domains (extramembrane and
transmembrane) in a single protein. The digestion pattern for these two domains vary, supporting
the notion that traditional protocols for soluble proteins are not amenable for membrane proteins.
The purpose of this work is to facilicate IMP analysis in strucutural proteomics.
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5.3. Materials and methods
5.3.1. General information
Unless otherwise noted, all materials were used as received from commercial sources without
further purification. Tris base ( >99.9% purity), urea, water, acetonitrile, formic acid were obtained
from Sigma-Aldrich Chemical Company (St. Louis, MO, USA). n-Dodecyl-β-D-Maltopyranoside
(DDM) was obtained from Anatrace. The membrane protein VKOR protein was provided by Dr.
Weikai Li, Department of Biophysics at Washington University in St. Louis. Chymotrypsin and
TECP-HCl were purchased from Thermo Fisher Scientific. Thermolysin, trypsin, pepsin,
ProteaseMAX™ surfactant are obtained from Promega. RapiGest surfactant was purchased from
Waters. Microcon-30kDa Centrifugal Filter Unit was from Millipore Sigma. The concentrations
of all the protein stock solutions were determined by UV absorption by using a Thermo
Scientific™ NanoDrop™.
5.3.2. Membrane protein VKOR sample preparation
DDM (3 mg) (Anatrace D310) was dissolved in 10 g Tris buffer (200 mM, pH=7.5) to make a
0.03% DDM solution. The resulting 0.03% DDM in Tris buffer was sonicated to ensure sufficient
solution. VKOR stock solution (1 mM) was diluted in 0.03% DDM Tris buffer to make a VKOR
solution (100 μM).
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5.3.3. Filter-aided sample preparation (FASP) for VKOR digestion

Figure 41. Workflow for filter-aided sample preparation(FASP).The protein sample was denatured during the x2
urea wash step. The vesicle ( e.g. micelle or lipsome) break apart and release detergent and lipids that are removed
by spin-down with urea solution.

The FASP protocol was modified slightly on the basis of previous literature[27] (the workflow for
FAS is described in Figure 41). Specfically, ultrafiltration units containing 50 µL VKOR (10 µM)
were added to 200 μL of denatured solution containing 8 M urea in 0.1 M ammonium bicarbonate
(pH 8.0), in the ultrafiltration units and centrifuged at 10,000g for ~ 20 min until less than 10 μL
of sample remains above the filter. Then, 200 μL of denatured solution was added to the
ultrafiltration units, and the wash step was repeated twice. The flow-through from the collection
tube was discarded, and 100 μL 50 mM TECP in 0.1 M ammonium bicarbonate was added to the
filter and incubated at 37 oC for 30 min. Iodoacetamide (IAA, 100 μL 100 mM) in 0.1 M
ammonium bicarbonate was added, and the resulting solution was placed in the dark for 30 min.
Centrifuge the ultrafiltration units at 10,000 g for ~20 min. Add 150 μL of digestion buffer (DB,
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0.1 M ammonium bicarbonate) to the filtration units and centrifuge at 10,000 g for 10 min. Repeat
this step twice. At this stage, urea and excessive IAA and TECP were removed by DB wash. Add
60 μL DB and protease (enzyme to protein ratio 1:20). Place the units in a water bath at 37°C
overnight. Note: The incubation of ultrafiltration units at thermomixer will result in evaporation
of DB overnight. The units were kept in water bath or a humid chamber at 37°C overnight. After
digestion, transfer the ultrafiltration units to new collection tubes. Centrifuge the ultrafiltration
units at 10,000 g until the solution completely passed the filter membrane. Add 100 μL of DB and
centrifuge the ultrafiltration units at 10,000 g until the solution completely passed the filter
membrane. Repeat this step. Combine the flow-through and add 1 μL formaic acid to acidify the
solution. The flow-through containing proteolytic peptides were used for subsequent MS analysis.
Concentration of the peptides was determined by using the Nanodrop.
5.3.4. Conditions screened

Table 6. The optimization of digestion condition

Entry

Protease

Additives

1

Trypsin

None

2

Chymotrypsin

None

3

Thermolysin

None

4

Pepsin

None

5

Chymotrypsin

Trifluoroethanol

6

Chymotrypsin

Urea

6

Chymotrypsin

Rapigest

7

Chymotrypsin

ProteaseMAX
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5.3.5. Mass analysis
5.3.5.1. Tandem MS/MS analysis
After the digestion, an aliquot (20 μL) of sample was diluted to 40 μL in 0.1% FA. 5 μL sample
was injected and loaded onto a custom-built silica capillary column packed with C18 reversedphase material (Waters Symmetry, 5 μm, 100 Å, 75 μm×30 cm;). The HPLC gradient was set as
follows: from 2.5% Solvent B (80 % acetonitrile,0.1 % formic acid) to 65% Solvent B over 80
min, then jumped to 98% Solvent B over 5 min at a flow rate of 0.5 μL/min, followed by a 10 min
wash at 98% Solvent B gradient. The HPLC column WAS then re-equilibrated with 2.5 % Solvent
B for 15 mins. A Q Exactive Plus hybrid quadrupole orbitrap mass spectrometer coupled with a
Nanospray Flex ion source (Thermo Fisher, Santa Clara, CA) was utilized for MS analyses. The
instrumental parameters were as follows: spray voltage of 3.0 kV; capillary temperature of 250 °C;
The Q Exactive Plus was operated in the data-dependent mode. Mass spectra were acquired in the
orbitrap (m/z 300−2000) with a mass resolving power of 70 000 at m/z 400 for MS1 and 17 500 at
m/z 17 500 for MS/MS. The fifteen most abundant ions were selected for HCD fragmentation at
an automatic gain control (AGC) target of 200 000. Previously selected ions were dynamically
excluded for 5 s.
5.3.6. Data analysis
LC-MS/MS raw files were imported into the Byonic™ Software (Protein Metrics, San Carlos, CA,
USA) coupled with an in-house database. Byonic™ processing of the LC-MS/MS data directly
provided sequence coverage, number of unique peptides under different proteolytic conditions.
Chosen were 20 ppm precursor mass tolerance, 60 ppm fragment mass tolerance, and CID/HCD
fragmentation. Modification fractions for certain peptides were interrogated with Byologic™
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software. Modification sites on the peptide were assigned on the basis of product-ion spectra
(MS/MS data).
5.4. Resutls and discussion
5.4.1. The evaluation of LC-MS/MS system

Figure 42. The extracted-ion chromatogram (EIC) of the most hydrophilic peptides A and B, and the two most
hydrophobic peptides C and D.Chromatographic peaks were integrated to estimate the relative abundance for
peptides A, B, C and D.
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Figure 43. The peptide intensity corresponding to acetonitrile percentage(left). The table of retention pepide list
(right).

Before analysis of the samples, we evaluated the performance of the LC-MS/MS system with
retention-peptide standard (RPS). The RPS contains 15 heavy isotope-labeled peptides with a
gradient hydrophobicity factors (HF) and at identical concentrations (0.5 pmol/µL) for each
peptides. Using RPS, we are able to calibrate the spectrometer and optimize and assess LC
parameters, identify the total peptide elution window, and optimize MS parameters.We injected
100 fmol of RPS per run (the EICs of selected peptides are in Figure 39). By measuring the
chromatographic peak areas for defined retention peptides (A,B,C,D), we found that the sensitivity
of defined peptides varied over nearly three orders of magnitude. For example, even we injected
same amount of A and D (100 fmol), peak integration for the most hydrophilic peptide A yields
1.5*109, whereas for the most hydrophobic peptide D, the peak integration gave only 1.6 *106.
There are many reasons to explain this observation that the amount of analyte does not always
produce a linear relationship with MS signal intensity.[28-29] Proteolytic peptides exhibit a wide
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range of physicochemical properties (e.g., size, charge, hydrophobicity, solubilization, ionization
efficiency) that leads to large differences in mass spectrometric response.
The sensitivity of hydrophobic peptides is determined partially by their solubility. Typically, acidic
peptides (containing Asp and Glu residues) can be reconstituted in basic buffers, whereas basic
peptides (containing Lys, Arg and His) can be dissolved in acidic solutions. For hydrophobic
peptides that contain large numbers of hydrophobic (e.g., Trp, Tyr, Phe) or polar uncharged amino
acids (e.g., Thr, Ser), organic solvent (e.g., acetonitrile, methanol, isopropanol) can be used to
increase peptide solubilites.
We then evaluated how an organic solvent can affect the sensitivity of peptides with different HF.
We choose RPS because it contains 15 isotope-coded peptides with a gradient of hydrophobicity
(Figure 40, right). We prepared the RPS in solution with different percentages of acetonitrile. We
plotted peak intensities for peptides A, B, C and D to monitor their mass response as a function of
acetonitrile concentration (Figure 40, left). We observed a binary mass response corresponding to
organic solvent. First, the intensity for the most hydrophobic pepetides C and D increased more
than two orders of magnititude when we increased the concentration of acetonitrile (see blue and
green curve). This observation is consistent with the principle that organic solvents facilitate
hydrophobic peptide solublization and with the results by Mitra et al[30] who observed a higher
percentage of predicted membrane proteins vs. non-membrane proteins when they used methanol
solublization. On the other hand, an opposite trend was observed for most hydrophilic peptides A
and B whose signal intensities decrease with an increasing concentration of acetonitrile.
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Figure 44. The valve system for sample loading. Typically, the system works in two mode. In the desalting mode, the
sample is flushed into desalting column that is directly connected to waste. Salts, contaminants and even hydrophilic
peptides can be removed in this step. After desalting, the system is switched to the gradient mode in which HPLC
pump elutes the analyte from the desalting column to analytical column for mass analysis.

It is clear that some hydrophobic peptides are practically lost when using organic solvent. Next,
we ask why? The proteolytic peptides in buffer solution possesses a variety of salts, detergents,
and other adduct-forming ions. These can interfere with MS characterization by decreasing
sensitivity and can result in instrument fouling, ultimately leading to downtime. To improve the
MS sensitivity, on-line desalting valves were applied in our LC-MS system to remove salts and
other buffer components prior to MS detection (Figure 41 shows an on-line desalting mode).
Ideally, the peptide sample was directly loaded into the desalting column to remove hydrophilic
matrix components (send to waste) while trapping peptides of interest. To ensure sufficient sample
loading and desalting, we usually employ 10 min elution with aqueous phase (0.1% formic acid).
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Because we observed decreased intensities for hydrophilic peptides A and B, we reasoned that
peptide A and B cannot be retained well on the desalting column with increasing fractions of
acetonitrile. That is, hydrophilic peptides partially wash away during desalting because they are
too hydrophilic. Even with a fraction of organic solvent, they can be partially eluted to waste. The
results here demonstrate that our LC-MS system is suitable for peptides having a certain
hydrophobicity window. By using organic solvents, the LC-MS system can be adjusted to favor
either hydrophilic (extramembrane) or hydrophobic (transmembrane) segments.

5.4.2. Protease screen

Figure 45. Peptide sequencing coverage for tryptic digestion of VKOR. PMI searach yielded nearly full coverage
(99.6%). Tryptic peptide containing transmembrane segments generate large, hydrophobic peptides. One example is
shown in Fig.47.
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Table 7. The protease for membrane protein digestion
Protease

Family

Cleavage Site

Optimal
pH value

Advantages

Trypsin

Serine
protease

C-terminal
of Arg and Lys

8.0

Efficient and specific;
Easy ionization and CID
fragmentation.

Chymotrypsin

Serine
protease

8.0

Orthogonal to that of trypsin;
preference for hydrophobic amino
acids

Pepsin

Aspartic
protease

C-terminal
of Phe, Tyr,
Leu, Trp and
Met
C-terminal
of Tyr, Phe and
Trp

1.0-3.0

Remains active at low temperature
(4 °C) and pH (2.5), which is
essential for HDX experiments.

N-terminus of
Leu, Phe, Val,
Leu, Ala, Met

8.0

Thermostable metalloproteinase (7095 oC). The high digestion
temperatures may be used as an
alternative to denaturants.

Thermolysin

Metallopro
tease

Limitations
The absence of positively charged
residues (K, R) at TMs; the
presence of negatively charged
amino acids such as D, E
prevents tryptic cleavage.
Lower specificity; the efficiency of
chymotrypsin toward different
hydrophobic amino acid residues
varies
Lower and pH-dependent
specificity. Pepsin has a preference
for aromatic residues (Y, F and W)
and L
Lower specificity; Mass parameters
are needed to be tuned to analyze
short peptides.

Bottom-up proteomics focuses on the analysis of protein mixtures after enzymatic digestion of the
proteins into peptides. The activities of different proteases differ in terms of specificity and
digestion efficiency.[31] As the prevalent enzyme choice, trypsin has been the gold standard as it
exhibits specific cleavage property, causes little self-digestion, and generates charged residues (i.e.,
Lys and Arg) at the C-termial of the peptides, making them suitable for MS ionization and
fragmentation. Traditional trypsin-centric strategies, however, are not efficient for IMP digestion
for several reasons. First, transmembrane domains are generally devoid of charged Lys and Arg
needed for tryptic cleavage. Thus, tryptic peptide containing one α-helices from the transmebrane
region are inevitably large and highly hydrophobic. These large and hydrophobic peptides may
readily adhere to plastic surfaces, may be retained by the LC column, or not detected by the mass
spectrometer. Second, even though these peptides are detected, they usually are retained a long
time in the reserved-phase column with resultant peak broadening. These broad peaks do not
provide enough resolution for residue-level or even peptide-level structural information in protein
structural characterization. Although we

obtained 99.6% sequence converage from tryptic

digestion, we still face the problem of long hydrophobic peptide resulting from trypsin cleavage
(demonstrated in Figure 46).
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Figure 46. Tryptic peptide (101-127) from VKOR.(a) The product-ion (MS/MS) spectra (top) and LC peak (bottom)
for peptide 101-127. The peptide is eluted showing a broad peak ranging from 101-105 min. (b) Peptide (101-127)
mapped on the X-ray crystal structural locates the peptide at the transmembrane domain.

Next, we used alternative proteases, including semi-specific or nonspecific proteases, to see if we
can obtain smaller, more informative peptides. We screened several proteases whose properties
are summarized in table 7. Specially, chymotrypsin preferentially cleaves at C-terminal of
aromatic amino acids Tyr, Phe and Trp at high rate, and at Leu and Met at lower rate. Thermolysin
cleaves at the N-terminus of Leu, Phe, Val, Ile, Ala, Met. Both enzymes can maintain their
enzymatic activity at pH 8.0, which is standard pH for most proteomic studies. Pepsin has its
highest activity between pH 2–4, and preferentially cleaves C-terminal of

aromatic and

hydrophobic residues Y, F,W and L, or even after A and G, its specificity being pH dependent.[3233]

To date, pepsin is the most commonly used protease for HDX of membrane proteins[34] owing
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to need to maintain enzymatic activity at pH = 2.5[35], a pH where the protein has minimal HDX
back-exchange.

Figure 47. The sequence coverage and number of unique peptides with several proteases.The number of unique
peptides decrease with the enzymatic specificity. That is, trypsin generates lowest number of unique peptides (107),
whereas nonspecific enzymes generate the highest number (e.g themolysin generates 245, and pepsin generates 240
peptides).

We evaluated the number of unique peptides and sequence coverage for a set of enzymatic
conditions (Figure 47). Of those, trypsin gives the highest coverage (99.6%) but with the lowest
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number of unique peptides (107 unique peptides). This observation is due to the high specificity
of trypsin that cleaves peptide chains on the C-terminal side of Lys or Arg. On the contrary, pepsin
generates a high number of unique peptides (240 peptides) but with moderate coverage yield
(74.7%). Because pepsin is a highly nonspecific protease, it could potentially cleave proteins into
small pieces, explaining our observation of a high number of unique peptides. Some peptide
regions, however, are so small that they are even beyond the detection capacity for most LC-MS
systems (see explanation in section 2.6.1) owing to their high hydrophicility or in an m/z range too
low to be included in our data dependent acquisition (DDA) parameter setting.

Figure 48. The sequence coverage for chymotrypsin (in green) and thermolysin (in blue) digestion.The two proteases
generate two sets of overlapped peptides that increase the confidence for peptide identification. The combined
outcome of two proteases is nearly a full sequence coverage (99.6%). Red dots represent modifications on residues
(e.g., oxidation, carbamidomethylation or carbamylation).

Notably, chymotrypsin and themolysin give equal coverage (94.4%) but generate different sets of
peptides (Figure 48. Chymotrypsin cleaves C-terminal side of amino acids while thermolysin
cleaves at the N-terminal side. The complementary nature for these two enzymes shows great
promise for IMP bottom-up analysis if one wishes to generate overlapping peptides for high
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confidence and good spatial resolution peptide identification. Indeed, we observe 99.6% sequence
converage with a combination of these two proteases, with only one methione at the N-terminus
that is not detected.
5.4.3. Additives screen
Chemical additives (e.g. organic solvent, chaotropes, or detergents) provide effective means for
IMP denaturation and solubilization. These agents have been widely used in classical proteomics
to improve IMP enrichment and digestion. For example, assisted by sonication, Veenstra and
cowokers[36] use the organic solvent methanol to identify over 700 IMPs , including peptides from
transmembrane segments. Using trifluoroethanol (TFE), Choolani and cowokers[37] found TFE
markedly prefers to release peptides with high hydrophobicity, suggesting a potential for TFE as
a complementary solvent for IMP analysis. Acid-labile detergents have been developed as
compared as a substiture for organic solvents or surfactant (e.g., sodium dodecyl sulfate). The
purpose of these agent is solubilize the protein and to simplify the detergent removel prior to LCMS. They usually contain two parts, one is a hydrophobic tail that becomes water immiscible and
forms easily removable precipitate after decomposition, whereas the other part is LC-MS friendly,
and it can be removed by on-line desalting (Figure 46 shows chymotryptic digestion results for
different additives). We found the incorporation of those additives gives comparable coverages
(Figure 49), in contrast with other studies that show additives improve digestion efficiency.[8]
Because we applied FASP, we reason that the VKOR membrane protein was fully denatured
during the step where we employed 8 M urea to release the membrane protein from the vesicle.
Further, the VKOR membrane protein undergo irreversible denaturation because the VKOR
disulfide bonds were immediately reduced with TECP followed by Cys alkylation.
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Figure 49. A screen of additives for chymotryptic digestion.The use of addtives did not improve sequence coverage.
Specifically, chymotrptic digestion yielded the highest coverage 94.4% with no addtives, 88.8% coverage with 10%
TFE, 87% coverage with 0.1% RapiGest, and 88.1% coverage with ProteaseMAX. The coverage decreases to 79.3
when 2 M urea was employed, persumbly due to its negative impact on protease activity.

We also found urea is less potent for IMP digestion. Even with 2 M urea, we observed decreased
coverage (79.3%) compared to other conditions. It should be noted that commonly used chaotropes,
such as 1 M guanidine and 2 M urea, are compatible with most proteases. Our results, however,
suggest that 2 M urea may reduce the enzymatic ability to achieve full coverage. Our result is
consistent with that of the Heck group[11] who found no benefits of 2 M urea for trypsin digestion
efficiency in term of the identified membrane protein.
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5.4.4. “Sweet Spot” for transmemrbane peptides detection
Even with an optimum solublization strategy, the coverage cannot improve unless peptides are of
a size and hydrophobicity compatible with current bottom-up technoglogies. Practically speaking,
the linear dynamic range of quantification is limited to be 10- to 20-fold depending on the
sensitivity of the instrument and complexity of the sample. This limitation affects the scope of
quantitative proteomics.
In section 5.4.1. we systematically evaluated the performance of the LC-MS/MS system by using
RPS. We found the MS sensitivity between the most hydrophilic peptides A and the most
hydrophobic peptide B varied by more than three orders of magnitude. IMPs are amphipathic –
composed of hydrophilic extramembrane segments and hydrophobic transmembrane segments
that occupy the phospholipid bilayer. Recognizing this “split personality”, we next test how
differently these two-segment peptides respond to MS detection.

Figure 50. The EIC for selected peptides: (a) EIC for lowest abundant chymotryptic peptides. (b) EIC for the most
abundant chymotryptic peptides. Nine of 10 lowest abundant peptides come from hydrophobic transmembrane domain,
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whereas 9 of 10 most abundant peptides from extramembrane. The selected peptides are mapped in the VKOR crystal
structure (PDB 3KP9 ).

The bacterial form of VKOR, which is naturally fused to a Trx-like domain, contains 285 amino
acids. Based on the VKOR crystal structure[38], it consists of a membrane-embedded five α-helix
(including ~180 amino acids) that is connected via a linker segment to the extracellular Trx-like
domain (including ~105 amino acids). To determine peptide sensitivity, we examined the EIC for
20 selected peptides, including the 10 most abundant and the 10 least abundant. This comparison
reveals a secret so far hidden in membrane proteomics. For the 10 highest abundant peptides, nine
of are from extramembrane. On the other hand, for the 10 lowest abundant peptides, nine are from
the transmembrane region. The EIC between the highest abundant peptide and the lowest varies
over three orders of magnitude, consistent with the behavior from RPS (see Figure 39) .
Interestingly, the eight highest abundant peptides contain positively charged residues (either Lys,
Arg or His), which improve their solublity and ionization efficiency. Among the 10 lowest
abundant peptides, nine have no positively charged residues. Only one miscleavage peptide
(sequence PTWIINGRTY) contains one Arg (Figure 47a). This finding provides direct evidence
for the “split personality” for IMP. Because transmembrane peptides are devoid of positive
charged residues, they are often under-represented in MS analysis. Current LC-MS system are
programmed to favor peptides containing positively charged amino acids. Chymotryptic peptides
from transmembrane domain are intrinstically hydrophobic because they are devoid of charged
residues.
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Figure 51. Identification of the “sweet spot” for membrane protein peptides detection at QE Plus.A and B are the
most hydrophilic peptides from RPS whereas C and D are most hydrophobic peptides. The calculation defines a
“sweet spot” between the blue line (maximum hydrophobic line ) and red line (most hydrophilic line). The HF for
most detected peptides from transmembrane belongs to the “sweet zone”.

Our next goal is to determine peptides comptiable for MS detections. By using the Peptide
Analyzing Tool from Thermo Fisher Scientific, we simulated the HF for peptides A,B, C, and D
from RPS. The calculated values define a “ sweet spot” between the most hydrophobic peptide D
and most hydrophilic peptide A (see region between blue line and red line in Figure 47). We
found that most detected peptides from transmembrane region are located in this “sweet spot”.
Further, there are more than half of detected transmembrane peptides whose HF is above 20. This
“sweet zone” offers guidance to choose a protease that can best cleave IMP into peptides.
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5.5. Conclusion
To date, most methods for membrane potein bottom-up analysis are aimed at discovery proteomics
that takes as a goal increasing the number of membrane protein and PTMs that can be identified
at the proteome level. These studies undoubtedly afford powerful approaches used for both
discovery and targeted proteomic analysis to understand global proteomic in a cell, tissue or
organism. There is also a need, however, for more directed or targeted approach for studying
specific membrane protein or membrane protein complex, as in structural proteomics. Structural
proteomic based tools (e.g. HDX, protein footprinting) typically rely on these targeted approaches
to generate sutitable peptides for structural chracaterization.
In the research reported in this chapter, we determined the optimized conditions to generate
membrane protein peptides by in-solution protein digestion for bottom-up proteomics. Specially,
we utilize RPS to calibrate the mass spectrometer and test the impact of organic solvents on an
LC-MS system; we applied FASP that can convinently remove detergent and contaminants; we
screened four different proteases (i.e., trypsin, chymotrypsin, thermolysin, and pepsin) and five
additives (including organic solvents, chaotropes, and acid-labile surfactants), and achived nearly
full coverage. Last but not least, we define a “sweet spot” that determines the capacity for LC-MS
system to deal with the wide range of hydrophobic and hydrophilic peptides from IMPs. This
outcomes provides guidance to choose a suitable protease in structural proteomics. We summarize
our findings below:
1) By using RPS, we are able to calibrate our instrument capacity for detecting difficult peptides
(peptides too hydrophilic or too hydrophobic). We found the use of acetonitrile increases the
intentisity for hydrophobic peptide, whereas organic solvents may comprosie the intensity for
hydrophilic ones. Reversed-phase chromatographic approaches are particularly well suited for
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peptides falling within certain window of hydrophobicity. Thus, careful column selection and
method development are required for effective peptide capture or detection when using
reversed-phase methods.
2) An optimized condition can generally yield >90% sequence coverage. Trypsin gives the best
coverage (99.6%), but its use generates peptides not suitable for strucutural proteomics studies.
In structural proteomics, there are certain proteins where trypsin digestion alone is inadequate.
Digestion with an alternative protease, individually or in combination, creates a unique peptide
map that may include sequences not seen with single protease. For example, we achive nearly
full coverage of VKOR by using a combination of chymotrypsin and thermolysin. Overlaying
peptides obtained with these two proteases increases protein coverage and overall confidence
in protein identification
3) The use of FASP is not restricted by sample origin. FASP can efficiently remove detergent or
lipids prior to MS analysis. This incorporation of FASP significantly decreases our workload
for sample preparation and allows us to avoid common contaminants that impair liquid
chromatography and hamper peptide ionization. We also found that additives are not neccessay
in FASP because the protein has already unfolded with the high concentration of urea wash
that we use.
4) For our model VKOR system, we found that peptides generated from the transmembrane
domain produce lower signal intensities than the ones from the extramembrane region. This
divided behavior is largely due to poor solubility or ionization efficiency for transmembrane
peptides because they lack of positively charged residues.
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5) We located a “sweet spot” in which most peptides in the transmembrane domains can be
detected. The “sweet zone” is particularly helpful in structural proteomics where usually a
single protein or protein complex is under investigation. For example, in silico digestion for
target protein predicts the peptides from a chosen protease. A hydrophobic factor (HF) is then
calculated for these proteolytic peptides. If the peptides’ HF places them in the “sweet spot”,
these peptides are likely to be detected. If not, alternative protease or MS parameters should
be selected to favor peptides from that protein system.
We also point out that there are still challenges or limitations of our developed protocols. First, the
combined use of chymotrypsin and thermolysis can generate high coverage for targeted IMP, but
they also undergo self-digestion. Because these self-digestion peptides are very difficult to be
removed prior to mass analysis, they compete with the peptides from the protein under study,
taking up time in the duty cycle of MS scanning. Fortunately, the fast speed of modern MS and
high-resolution chromotogrphy will enable enough scanning space for targeted peptides in simple
protein systems even when the analyte peptides are mixed with protease peptides. Second, as IMP
has various structure and they are usually reconstituted in different vesicles, there is a need for
further validation of the effectiveness of this protocol to various biosystems. Future studies will
aim to use this protocol for memembrane protein structural characterization, expand the scope to
other IMP systems, and incoporeate quatatitative measures for IMP studies.
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Chapter VI. HDX-MS for determination of
the protein interaction of alphaviruses in the
receptor Mxra8 complex

This chapter is partially based on a recent published paper: Katherine Basore, Arthur S. Kim,
Christopher A. Nelson, Rong Zhang, Brittany K. Smith, Carla Uranga, Lo Vang, Ming Cheng, Michael L.
Gross, Jonathan Smith, Michael S. Diamond*, and Daved H. Fremont*. “Cryo-EM structure of
Chikungunya virus in complex with the Mxra8 receptor”. Cell. 2019, 177, 1725-1737.e16
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6.1. Abstract
Mxra8 is a receptor for multiple arthritogenic alphaviruses that cause debilitating acute and chronic
musculoskeletal disease in humans. These viruses cause endemic diseases and worldwide
epidemics. However, no specific therapeutic approaches have been developed to treat infections
caused by alphaviruses. Structures of the multiple arthritogenic alphavirus receptor Mxra8 as well
as Mxra8 in complex with anti-Mxra8 monoclonal antibodies (mAbs) and chikungunya virus
reveal the mechanism underlying viral invasion and may facilitate the development of novel
vaccines and entry inhibitors. In the research described in this chapter, we applied
hydrogen−deuterium exchange mass spectrometry (HDX-MS) to study the interactions of Mxra8
and mAbs. Using HDX-MS, we identified critical peptide regions involved in the recognition of
Mxra8 by eight different mAbs. The HDX data classify the anti-mAbs into three classes, which is
consistent with bio-layer interferometry (BLI) assay, but it affords a higher spatial resolution at
peptide level. Additionally, our HDX data support that competing mAbs share same binding sites
with virus protein on Mxra8 receptor. Combined with BLI assay, HDX-MS helps to assign a model
for Mxra8 orientation which is favored by docking modeling. These data demonstrate the value of
HDX-MS as part of an integrative tool in the emerging toolbox of structural biology.
6.2. Introduction
6.2.1. The worldwide epidemics of Chikungunya alphaviruses
Alphaviruses are enveloped, single stranded RNA viruses transmitted primarily by mosquitoes.
They include chikungunya (CHIKV), Mayaro (MAYV), O’nyong’nyong (ONNV), and Ross
River (RRV) viruses. These viruses are distributed worldwide and cause debilitating acute and
chronic polyarthritis, affecting millions of people in Africa, Asia, Europe, and the Americas.[1-2]
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Despite their widespread epidemics, no specific therapeutic approaches have been licensed to treat
infections caused by alphaviruses.[3-4]

Figure 52. CHIKV virus geographic distribution(reported by September 17, 2019). Prior to 2013, CHIKV cases and
outbreaks had been identified in countries in Africa, Asia, Europe, and the Indian and Pacific Oceans. In late 2013,
the first local transmission of CHIKV virus in the Americas was identified in Caribbean countries and territories.
Local transmission means that mosquitoes in the area have been infected with the virus and are spreading it to people.
The

virus

then

spread

throughout

most

of

the

Americas.

Data

were

cited

from

https://www.cdc.gov/chikungunya/geo/index.html.

CHIKV is one most common alphavirus infecting humans worldwide. It was firstly described by
Robinson[5] in 1955, after an epidemic of dengue-like fever with extremely severe joint pain in
Southern Tanganyika (now Tanzania) in 1952–1953. Its name originated from the Kimakonde
language meaning “that which bends up” for its clinical manifestation. Between outbreaks,
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CHIKV circulates in a sylvatic cycle where non-human primates are the main host,[6-7] and
mosquitoes are the main vector. If a human is bitten by an infected mosquito, sporadic human
cases can originate from the cycle.[8] The symptoms caused by CHIKV vary from fever or rash to
severe arthritis.
6.2.2. The structure of CHIK virus-like particles (VLPs)
CHIKV is an enveloped, positive-stranded RNA virus that contains two types of structural proteins,
capsid (CP) and three envelope glycoproteins (GPs) (E1, E2 and E3).[9] Cryo-EM structure of
virus-like particles (VLPs) revealed that virions are composed of two icosahedral layers: the outer
envelope layer and the inner nucleocapsid (NC) core. The envelope comprises 80 membrane
embedded spikes, with each spike formed by a trimer of the E1–E2 heterodimer (Figure 53A).[1013]

CHIKV takes 240 copies of CP to form an NC core enclosing the viral genomic RNA inside

(Figure 53B, C). Each CP interacts with the cytosolic domain of E2, while E1 is a membrane
fusion protein and it sits at the base of trimeric spike. E1 consists of three domains[11]: domain I
links distal domain II and membrane proximal domain III. A fusion loop is located at the distal
end of E1 domain II. Crystal structures of CHIKV E1E2 heterodimer revealed three domains in
E2:[14] domain A is located in the center of the spike surface, while domain B and C are located at
the distal end and the membrane proximal end of E2, respectively. Notably, the apex of domain A
and a part of domain B possess the putative binding site for receptor,[15] which is confirmed by the
recent identification of a shared receptor, Mxra8.[16]
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Figure 53. Structure of Chikungunya virus (CHIKV) and envelope glycoproteins.Cryo-EM density map of (A) CHIK
virus-like particles (VLP), (B) CHIK VLP viewed at the cross-section, and (C) CHIK nucleocapsid core, colored
according to the radial distance from the center of the virus;(D) Structure of the p62-E1 heterodimer (PDB:3N40).[17]
The figure is cited from reference.[4]

6.2.3. Mxra8 is a potential therapeutic target for CHIK virus
Spreading rapidly from endemic areas of Africa and Asia to Europe and the Americas, CHIKV is
now the most common alphavirus infecting humans globally.[18] Despite the widespread epidemics,
there are no vaccines or treatments licensed for CHIKV infection.[4] In the past decade, several
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potent human and mouse anti-CHIKV mAbs were isolated and demonstrated to be protective in
vivo.[19-27, 18]
The host factors required for alphavirus entry remain poorly characterized. Recently, Diamond and
coworkers utilized a genome-wide CRISPR–Cas9-based screen to identify the cell adhesion
molecule Mxra8 as an entry mediator for multiple arthritogenic alphaviruses, including CHIKV,
MAYV, ONNV and Ross River viruses.[16] It was found that Mxra8 cell surface expression was
required for efficient infection of primary human target cells. Mxra8 binds directly to CHIKV
particles to increase attachment and internalization into cells, and anti-Mxra8 monoclonal
antibodies (mAbs) blocked CHIKV infection of several cell types. Further, several human mAbs
targeting epitopes in E2 domain are able to inhibit binding of Mxra8 to CHIKV.
Although Mxra8 is believed to bind to the surface-exposed region of E2 and facilitate virus
attachment and internalization, the detailed mechanism by which Mxra8 engages the alphavirus
spike protein is not clear owing to the lack of structural information. To elucidate the interaction
mechanism, Fremont and coworkers[28] recently described the X-ray crystal structure of Mxra8
and the cryo-EM structures of Mrax8 with CHIKV virus-like particles (CHIKV VLPs) and
infectious virus. From the crystal structure, Mxra8 consists of two Ig-like domains with a unique
topological structure (Figure 54). The two Ig-like domains arranged in a head-to-head orientation,
with the CDR-like loops pointing towards one another. The two FG-loops (CDR3-like) are
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Figure 54. Mxra8 crystal structure and topology diagram(A) Ribbon model of the mouse Mxra8 protein structure.
The two Ig-like domains are colored from the N to C terminus in a rainbow spectrum of blue to red, with the disulfides
shown as yellow ball and stick bonds (Cys143-Cys278). The N and C termini are labeled in lowercase. (B) Secondary
structure diagram of Mxra8, numbered by sequence positions in the X-ray structure. (C) Cartoon schematic of Mxra8,
with labeled D1 and D2 domains, N and C termini, B-C linkers, and cysteine residues forming the interdomain
disulfide bond. The figure is cited from reference. [28]

connected by a disulfide bond (Cys143-Cys278 bond as shown in Figure 54). Domains D1 and
D2 are similar in sequence and nearly identical in fold. The hinge connecting the two domains is
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flexible, and comparison of the two independent Mxra8 structures indicates that domain D1 can
move by at least ~43o relative to D2.[29]
Nevertheless, there has been limited structural information of the Mxra8 receptor interaction with
enveloped viruses. There is a clear need for a detailed structural analysis that defines how CHIKV
engages its receptor Mxra8 to facilitate attachment and infection of cells. This information will
inform therapies and lead to improved vaccine designs that mitigate disease of multiple emerging
alphaviruses.
6.2.4. Hydrogen-deuterium exchange mass spectrometry
6.2.4.1. The role of HDX-MS in structural biology
Protein structural elucidation is an essential prerequisite for deciphering their role in health and
disease. A comprehensive understanding of biological function requires many aspects of protein,
including structure, conformation or dynamics. Undoubtedly, X-ray crystallography, Cryo-EM,
and NMR spectroscopy are the most important methods that are routinely being applied for
structural studies. Those methods contribute almost all high-resolution protein structure deposited
in protein data base (PDB). While these methods can determine high-resolution protein structures,
they can be limited by requirements such as crystallization, isotopic labeling, protein size, and low
throughput.
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Figure 55. Synopsis of the published applications of HDX-MS from January 2012 to June 2014.(A) 234 articles were
published and classified based on author affiliations. (B) The global distribution of the articles in panel A, based on
home institutions for communicating author. (C) The USA distribution of the articles (D) Breakdown of the non-USA
publications according to country and to sector. (E) The six classifications for HDX-MS application.
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In the past decades, a rapidly increasing number of research initiatives use mass spectrometry (MS)
in structural biology. Hydrogen-deuterium exchange mass spectrometry (HDX-MS) is one pivotal
tool in structural mass spectrometry. HDX-MS has been used in the study of protein structure,
interactions, folding, membrane protein, and biopharmaceuticals, and it is continuously being
refined (Figure 55). It can readout protein structure information in moderate resolution (peptide
or residue level), but it can provide complementary structural information that are not accessible
by other techniques. The breadth of applications of the method has expanded in many areas, which
are summarized in recent reviews.[30-32]
6.2.4.2. HDX-MS principles
Hydrogen atoms in O–H, N–H, and S–H groups are labile. They can readily exchange with
hydrogen cation from surrounding water. When protein sample are exposed to a D2O-containing
environment, it will lead to H – D replacements that increase the mass of the protein by one unit
per exchange event.
Typically, only deuterium exchange at backbone amide hydrogens are measurable by MS. Since
all residues (except prolines and the first amino acid in the chain) possess an amide N–H group,
HDX-MS is a powerful method to probe structure affecting the entire protein. The rate of HDX
depend on multiple factors, including D2O, temperature, and pH. The key factor to enable HDX
application in structural studies is the fact that the N–H→N–D conversion rate is modulated by the
high-order structure of protein. That is, the ordered protein regions are less amenable to exchange
because amide bonds possess a multitude of intramolecular hydrogen bonds with nearby residues.
Both factors contribute to protection of the affected amide(s), such that the overall rate constant
HDX is less for that region. Rate constants of the opening and closing transitions are designated
as kop and kcl, respectively.[30] Their relationship can be described as following scheme.
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The scheme describes the overall exchange mechanism where an N–H group may exhibit a unique
combination of kop, kcl, and kch. These exchange events are mediated by conformational
fluctuations of the protein. Nonetheless, even protected amides can undergo HDX at measurable
rates.
6.2.4.3 Two modes of HDX-MS
Depending on how a protein sample is incubated with D2O, HDX-MS utilizes D2O to label protein
either in a continuous or a pulsed strategy. In continuous labeling, a native protein is incubated in
D2O buffer, where deuterium incorporation can be monitored as a function of exposure time. The
time points can be typically manipulated from seconds to hours. During the labeling time, flexible
regions (e.g., loop region, N-terminal or C-terminal) that spend a considerable fraction of time in
open conformations undergo faster exchange. On the other hand, in tightly folded region, the amide
bond undergoes less exchange because folded regions are generally less dynamic. The divergence
in the exchange can be reflected in mass shift that can be readily measured by MS. Pulsed HDX is
used primarily for the detection and characterization of short-lived folding intermediates.[33-35] In
these studies, the initial state protein is placed in a suitable solvent environment, followed by
triggering the folding process. Subsequently, the protein is labeled with D2O at a well-defined time
point. The protein states can be measured by varying the time interval between folding trigger and
pulse. In this mode, it is possible to obtain detailed insights into the events that lead from the
disordered state to the native or aggregated state. Compared to continuous HDX labeling, the
pulsed HDX typically requires basic conditions (pD = 8–10) to ensure that extensive isotope
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exchange can occur during the short labeling step. The labeling pulse may be quenched by rapid
acidification to pH 2.5.
6.3. Materials and methods
6.3.1. General information
Unless otherwise noted, all materials were used as received from commercial sources without
further purification. PBS buffer tablet, Tris (2-carboxyethyl) phosphine hydrochloride (TCEP-HCl)
and guanidine hydrochloride , water, acetonitrile, formic acid were obtained from Sigma-Aldrich
Chemical Company (St. Louis, MO, USA). Cell adhesion receptor Mxra8, anti-Mxra8 monoclonal
antibodies were provided by Dr. Daved H. Fremont and Michael S. Diamond from school of
medicine at Washington University in St. Louis. The concentrations of all the protein stock
solutions were determined by UV absorption using Thermo Scientific™ NanoDrop™.
6.3.2. HDX-MS workflow

Figure 56. The platform for continuous HDX-MS
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Figure 56 shows the workflow of HDX-MS. Continuous HDX labeling of Mxra8 with or without
the mAbs was performed at 25°C for 0, 10, 30, 60, 120, 900, 3,600, and 14,400 s as previously
described[36] with the following modifications. Briefly, stock solutions of Mxra8 both with or
without the mAbs were prepared in PBS (pH 7.4) and incubated at 25°C for at least 1 h. Continuous
labeling with deuterium was initiated by diluting the stock samples 10-fold in deuterated PBS
buffer. HDX control samples (nondeuterated) were prepared in the same way with H2O.
Quenching was performed under reducing conditions by adding a solution of 500 mM Tris (2carboxyethyl) phosphine hydrochloride (TCEP-HCl) and 4 M guanidine hydrochloride in PBS
buffer (pH 7.4, adjusted using sodium hydroxide) to the reaction vial at a 1:1 vol/vol ratio. The
sample was mixed and incubated for one minute at 25°C before being loaded onto our custombuilt HDX platform for desalting, online pepsin digestion, and reversed-phase separation and
directly injected into the mass spectrometer for analysis.
The sample was passed over a custom-packed 2- by 20-mm pepsin column at 200 µL/min;
immobilized pepsin was prepared according to a published protocol.[37] The peptides resulting
from digestion were captured by a 2.1- by 20-mm Zorbax Eclipse XDB-C8 trap column (Agilent)
and desalted at 200 µL/min of H2O containing 0.1% trifluoroacetic acid for 3 min. The peptides
were separated by a 2.1 x 50 mm C18 column (2.5-µm XSelect CSH C18; Waters) with a 9.5 mins
gradient of 5 to 100% acetonitrile in 0.1% formic acid at a flow rate of 100 µL/ min. The linear
part of the gradient from 0.3 min to 5.5 min raised the acetonitrile content from 15% to 50%,
during which time most of the peptides eluted from the C18 column. The entire fluidic system was
kept in an ice bath, except for the pepsin column, to minimize back exchange. Duplicate
measurements were carried out for each of the time points.
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6.3.3. HDX data analysis
Acquired spectra were analyzed using HDX workbench software[38] against a peptide set generated
as described below. The deuterium level was normalized to the maximum deuterium concentration
(90%) contained in the reaction vial. The peptide list used to search the HDX data was identified
first by a tandem-MS experiment in a data-dependent mode on a linear trap quadrupole-Fourier
transform (LTQ-FT) mass spectrometer (Thermo). The six most abundant ions were submitted to
collision-induced dissociation fragmentation. Product-ion spectra were then submitted to Byonics
for identification and manually inspected, and the validated peptides were used for the HDX
analysis. The epitopes were identified as regions/sequences of amino acids (not single residues)
that show a significant difference in HDX for the bound versus unbound states, as determined from
the peptide-level HDX-MS data.
6.4. Results and discussion
6.4.1. Mxra8 mapping with isotype mAb
We began this study by using HDX−MS to map Mxra8 and Mxra8-isotype mAb complex. We use
Byonics to search the sequence coverage against a custom database (containing sequence for
Mxra8 and pepsin). Figure 57 shows the coverage for Mxra8-isotype mAb complex. We obtained
nearly full coverage of ∼99% for Mxra8 by using pepsin. Specifically, we obtained 97 unique
peptides with high confidence and a total 258 by MS/MS scanning for peptide of interest. The
near-full coverage is a prerequisite to locate comprehensively the interaction interfaces on Mxra8
upon binding to anti-Mxra8 mAbs. As we do not include glycosylation in our default modification,
we are able to conclude that Mxra8 is not glycosylated because we obtain 99% coverage without
setting glycosylation modification in the search.
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Figure 57. HDX-MS peptide mapping for Mxra8-isotype mAb complex.99% coverage was obtained with 97 unique
peptides and 258 MS/MS scans.

Figure 58. Perturbation view of Mxra8/ Mxra8-isotype mAb complex.The level of deuterium uptake %D for all time
points is rendered in colored horizontal layers. Gray color shows no significant protection of Mxra8 upon binding to
Mxra8-isotype mAb from deuterium exchange. Isotype mAb, which is validated as none Mxra8 binding mAb in
biological assay, serve as a negative control for HDX-MS mapping experiment.

A central feature for HDX-MS is its ability to determine if the differences between experiment
results are structurally significant. We used a none-Mxra8 binding mAb as control to determine
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the reliability for differential HDX data. Figure 58. displays colored differential HDX data
rendered onto the protein sequence. The difference level of deuterium incorporation measured as
a percentage (delta %D) and its associated standard deviation are displayed for each peptide to
facilitate the validation process. The bar at the beginning of each peptide represents the first two
residues in which the exchange rate occurs too quickly to be measured. Typically, delta %D
ranging from -10 to 10 is rendered as no significant HDX difference, and the bar is colored in gray.
From Figure 58, we conclude that isotype mAb don’t bind the Mxra8 since no significant HDX
difference was observed.
6.4.2. Mxra8 mapping with anti-Mxra8 mAbs
We then expanded our HDX inquiry to probe the interaction interfaces of Mxra8 and Anti-Mxra8
mAbs. It should be noted that several mAbs targeting epitopes in E2 domain of virus protein can
block CHIKV infection. This strategy utilized mAbs to neutralize the binding site on the virus
protein, rather than targeting Mxra8 to block virus infection. In our studies, an alternative strategy
involved to block virus infection. The synthesized mAbs were designed to target Mxra8 receptor
rather than the virus proteins. Since Mxra8 bound directly to CHIKV particles enhanced
attachment and internalization into cells, the anti-Mxra8 mAbs could effectively reduce CHIKV
infection by blocking CHIKV binding sites. In fact, administration of anti-Mxra8 mAbs to mice
reduced CHIKV infection and associated joint swelling.
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Figure 59. Perturbation view of Mxra8/ anti-Mxra8 mAb 7F1.D8 complex. The level of deuterium uptake %D for
all time points is rendered in colored horizontal layers. Green and light green color shows significant protection of
Mxra8 upon binding to mAb from deuterium exchange.

Although several biological characteristics of CHIKV interaction with Mxra8 are known, the
structural insight as to how Mxra8 interacts with virus or anti-Mxra8 is still lacking. We therefore
performed HDX-MS to probe Mxra8 interaction with a series of anti-Mxra8 mAbs. The
differential deuterium incorporation (delta %D) for each time point is rendered in colored
horizontal layers for each peptide, allowing for visualization of HDX protection in the panel.
Taking anti-Mxra8 mAb (ID: 7F1.D8), for example, comparison between the bound and unbound
states (Figure 59) establishes that peptides 44−50, 241−249 and 249−256 show significant
decreases in the rate of deuterium uptake, potential binding interfaces for Mxra8-mAb complex
(ID: 7F1.D8). Notably, with two peptides 224-240 that show no protection, we can exclude their
interaction on peptide 224-240 region although we observed a longer peptide 224-249 that contains
peptide region 224-240 and shows HDX protection. In this scenario, the condition that generates
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short and overlaying peptides in HDX is highly desired because it improves the resolution to locate
the exact binding position.

Figure 60. HDX plots of representative peptides of Mxra8in the unbound (red) and bound (black) states with antiMxra8 mAb 7F1.D8. The peptide, charge state, and amino acid sequence are indicated in each panel.

Next, we plotted the HDX kinetic curves that show differences in deuterium uptake for regions
represented by peptides 44−50, 44-51, 241−249 and 249−256. Peptide 44-50 and 44-51 shows
average >20% difference between the unbound and bound states, and their kinetic curves remain
unmerged even after 4 h incubation time. For peptide 241-249, the HDX difference is large at the
first three time points (10 s, 30 s, 1 min) but it seems to merge quickly at the last four incubation
time points (120 s, 900 s, 3600 s, and 14400 s). For peptide 249-255, their differences for deuterium
uptake remain relatively constant. On the hand, there were no significant deuterium update
differences observed for the rest of regions when Mxra8 is neutralized with anti-Mxra8 mAb
7F1.D8.
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6.4.3. The classification of anti-Mxra8 mAbs

Figure 61. The classification of anti-Mxra8 mAbs based on their HDX binding pattern.The kinetic curve (A) and the
heatmap (B) for eight different mAbs. The black curve represents for holo-state while the red line for apo-state.

With this robust HDX platform, we classified anti-Mxra8 based on their HDX patterns. We are
using this approach to identify these fingerprints as surrogates for mAb binding behavior in Mxra8
receptor. Figure 61 summarize HDX kinetic plots of peptides from mAbs of each of the three
classified groups. Regions are considered to contain the binding epitopes if they show reduced
rates or extents of hydrogen-deuterium exchange. All experiments were performed in duplicate,
and data are representative of two experiments. Heatmaps depict the average difference of
deuterium incorporation between the mAb alone and with Mxra8 present across all seven time
points (∆D%). Based on their HDX pattern, the mAbs can be classified as three groups: class 1 is
coded in yellow (mAbs 4E7.D10, 8F7.E1), and class 2 is coded in violet (mAbs 1G11.E6, 7F1.D8)
Class 3, which is coded in green, includes three mAbs 1H1.F5, 3G2.F5, 9G2.D6.
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6.4.4. HDX-MS predict shared binding sites for anti-Mxra8 mAbs and E2E1 virus

Figure 62. HDX-MS predicts binding sites shared by anti-Mxra8 mAbs and virus.The HDX kinetic curve for Mxra8
complex with isotype mAb (A) and anti-Mxra8 mAb 4E7.D10 (B). One binding region (C) of virus on Mxra8 awas
shown in Cyro-EM structure, which show as the same region detected by HDX-MS.

At current stage, the atomic structure for Mxa8 immune complex is not known. We are unable to
directly compare the HDX data with high-resolution structure. Biolayer interferometry (BLI)
competition binding assay revealed that mAbs 4E7.D10 and 8F7.E1 compete with virus protein to
bind with Mxra8. We now ask whether mAbs and virus proteins could compete and bind at the
same sites, and more importantly, where is the binding interface.
Mapping protected regions onto the crystal structure of Mxra8 illustrates that mAbs (4E7.D10 and
8F7.E1) bind at peptide region 92-108. We plot the HDX kinetic curve that shows significant
differences in deuterium uptake for region 92-108 (Figure 62B). Peptide 92-108 shows
average >20% difference between the unbound and bound states, and their kinetic curves remain
unmerged even after 4 h incubation time. When incubated with isotype mAb, however, Mxra8
shows no decrease in the rate of deuterium uptake (Figure 62A). Notably, our HDX results agree
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with the recently published X-ray structures that show CHIKV virus bind at same regions on
Mxra8.[39] Specifically, residues (Y92, E96, and R98) in the D2 regions of hMXRA8 are
predominantly involved in virus E2 binding (Figure 62C). All these residues belong to peptide
92-108, which is part of the binding interface successfully predicted by our HDX-MS epitope
mapping (4E7.D10 and 8F7.E1). In addition, the mutagenesis R98A, as well as the disruption of
the interdomain disulfide bond, destroyed virion binding on Mxra8, which further confirms that
peptide 92-108 is one binding interface shared by both the mAb and the virus.
6.4.5. HDX-MS facilitate to assign Cryo-EM structure for Mxra8 CHIKV virus complex
Recently, the Mxra8 virus complex was investigated by several research groups worldwide.[9, 39]
Aided by Cryo-EM structure and computational modeling, our collaborator (Dr. Daved H. Fremont)
reconstructed the high-resolution structure for Mxra8 bound to chikungunya (CHIKV) virus-like
particles and infectious virus.

Figure 63. Two model are proposed for the Mxra8 orientation upon binding to the E2E1 virus protein.Mxra8 model
shown in Figure 54 A is of the properly docked model, whereas the model shown in Figure 54B is poorly docked.
Combined with HDX-MS epitope mapping and BLI assay, we assigned the right model for Mxra8 orientation in its
virus complex. BLI assay was done by our collaborators, Dr. Daved H. Fremont group.
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In support of the docking model, BLI assay was first performed to reveal that Mxra8 cannot bind
to CHIKV VLPs in the presence of a subset of previously described anti-Mxra8 mAbs that inhibit
infection. Based on the BLI assay, these anti-Mxra8 mAbs can be classified into competing
(Figure 63, binding region are coded in yellow and purple) and non-competing ones (Figure 63,
binding region are coded in green).
Two modes are proposed for the Mxra8 orientation upon binding to the E2E1 virus protein. In one
mode (Figure 63A), the Mxra8 D1 domain oriented outside, with D2 domain deeply embedded in
a cleft of the CHIKV spike and proximal to the viral membrane. An alternative Mxra8 model
(Figure 63A), where the Mxra8 docking was flipped to position the D1 domain that inserts into
E2E1 virus protein while D2 extends away from the virion.
HDX-MS epitope mapping shows that competing mAbs bind to Mxra8 at its interface with CHIKV,
whereas non-competing mAbs bind at other sites (Figures 63A). For example, we observed
competitive inhibition with mAbs 4E7.D10 and 8F7.E1 (coded in yellow), which map to an epitope
in D1 of Mxra8 in residues adjacent to the E2 A domain of virus, and mAb 1G11.E6, whose epitope
in D2 residues is adjacent to the E1 fusion loop of virus. In contrast, mAbs 1H1.F5 and 3G2.F5,
which do not compete in the BLI assay, map to predominantly solvent-exposed peptides in D1. If
Mxra8 orientations were inverted, the epitope of mAbs 1H1.F5 and 3G2.F5 would be inaccessible
(Figure 63B), which is not consistent with our BLI assay. This mode (Figure 63B) also is not
consistent with the observed ability of mAb 1G11.E6 to compete for virus binding.
6.5. Conclusion
Mxra8 is a receptor for multiple arthritogenic alphaviruses that cause debilitating acute and chronic
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musculoskeletal disease in humans worldwide. Structural characterization of Mxra8 complex
should provide insight into how Mxra8 binds CHIKV and creat a path for developing alphavirus
entry inhibitors.
In this chapter, we applied HDX-MS to probe the interaction between Mxra8 and anti-Mxra8
mAbs. HDX-MS was able to report binding sites in a relatively fast fashion. We investigated eight
mAbs and classified them based on the corresponding HDX patterns. This classification is
consistent with BLI assay, but it affords higher spatial resolution at the peptide level. The HDXMS also successfully predicts that competing mAbs shared the same binding sites with the virus
protein on Mxra8 receptor. It explains the observation that Mxra8 cannot bind to CHIKV VLPs in
the presence of a subset of previously described anti-Mxra8 mAbs. Last but not least, HDX-MS
combined with BLI assay help to assign a model for Mxra8 orientation, which is favored by
docking. These results expand our understanding of the detailed mechanism underlying the
interaction between Mxra8 and mAbs and with CHIKV.
Further, structural biology is moving more and more in the direction of integrative approaches,
where structural data from different methods are combined with computational modeling. Mass
spectrometry, with its ability to measure small sample amounts at reasonable speed and sensitivity,
will undoubtedly play a pivotal role in integrative structural biology. This integrated approach can
optimize the design of protein therapeutics and be useful for characterizing protein and protein
complexes.
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6.7. Appendices

Figure 64. HDX-MS perturbation view of Mxra8/ anti-Mxra8 mAb 8F7.E1 complex.The level of deuterium
uptake %D for all time points is rendered in colored horizontal layers. Green and blue color shows significant
protection of Mxra8 upon binding to mAb from deuterium exchange.
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Figure 65. HDX-MS perturbation view of Mxra8/ anti-Mxra8 mAb1G11.E6 complex.The level of deuterium
uptake %D for all time points is rendered in colored horizontal layers. Green and blue color shows significant
protection of Mxra8 upon binding to mAb from deuterium exchange.

Figure 66. HDX-MS perturbation view of Mxra8/ anti-Mxra8 mAb 3G2.F5 complex.The level of deuterium
uptake %D for all time points is rendered in colored horizontal layers. Green and blue color shows significant
protection of Mxra8 upon binding to mAb from deuterium exchange.
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Figure 67. HDX-MS perturbation view of Mxra8/ anti-Mxra8 mAb 9G2.D6 complex.The level of deuterium
uptake %D for all time points is rendered in colored horizontal layers. Green and blue color shows significant
protection of Mxra8 upon binding to mAb from deuterium exchange.

Figure 68. HDX-MS perturbation view of Mxra8/ anti-Mxra8 mAb 1H1.F5 complex.The level of deuterium
uptake %D for all time points is rendered in colored horizontal layers. Green and blue color shows significant
protection of Mxra8 upon binding to mAb from deuterium exchange.
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7.1. Conclusion
Over the past 30 years, mass spectrometry has evolved as a new, productive tool for integrative
structural biology. Structural MS (structural proteomics) provides an abundance of information,
from protein primary structure and post-translational modifications (PTMs) to higher-order
structure, protein dynamics and interactions.
The power of MS to produce a readout structural information relies on advances in instrumentation
(e.g., tandem MS, soft ionization, ion mobility MS), in solution where biochemical reactions occur
(e.g., HDX,

covalent labeling and chemical crosslinking), and ever-increasing computer

technology (algorithm for peptide sequencing or de novo, and computational modeling).
My dissertation program centers around the development of new methods to sharpen the tools of
structural proteomics, with an emphasis on protein footprinting. The advances are summarized
below:
The first part focuses on protein footprinting methodology development. We extended the fastphotochemical oxidation of proteins (FPOP) platform by adding new radicals to improve
footprinting coverage, including increasing their broad chemical reactivities (Chapter II for • CF3
footprinting) and improve reagent lipid accessibility for IMP labeling (Chapter IV for sonication
mediated TMs labeling). We expand the application of •CF3 chemistry into the synchrotron
platform that is the second footprinting reagent that can be used on the synchrotron platform since
1999 (Chapter III for X-ray mediated •CF3 footprinting). The work serves as a proof-of-concept
to demonstrate that synchrotron is adaptable to other novel chemistries that enhance footprinting
coverage. Further, taking advantage of X-ray irradiation at synchrotron, direct protein
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trifluoromethylation in the absence metal catalysis or peroxide addition has been achieved, for the
first time.
The second part of the thesis is directed at methods for membrane protein proteomics. This
challenge is not only associated with footprinting (Chapter IV for transmembrane domain
labeling), but also is related to limitation of bottom-up mass analysis. We investigated an array of
in-solution digestion conditions using different combination of protease and additives to optimize
the coverage of IMP digestion (Chapter V for IMP digestion). The optimized conditions can
generally yield >90% sequence coverage and generate peptides suitable for structural proteomic
studies. The incorporation of FASP significantly decreases our workload for sample preparation
and allows us to avoid common contaminants that impair liquid chromatography and hamper
peptide ionization. Further, deep analysis enables us to identify a “sweet spot” that may provide
guidance to choose a suitable protease in structural proteomics in future.
In addition to methodology development, we used HDX-MS to characterize the binding interface
for Mxra8-immune complex. HDX-MS enables us to classify variousa novel mAbs. Combined
with a BLI assay, HDX-MS helps to assign a good model for Mxra8 orientation, a model consistent
with docking. Structural biology is moving more and more in the direction of integrative
approaches. The work provides a paradigm for integrative mass spectrometry that applied HDXMS, Cryo-EM and computational modeling in structural virology.
7.2. Limitation and challenges
On the other hand, we need to point out some limitations in current protein footprinting and
footprinting method development. First, unlike most spectroscopic methods, protein footprinting
relies on modifying a protein to encode a mass shift that is subsequently measured by MS. The
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modification may perturb the structure of protein. Thus, every new labeling procedure must be
carefully controlled and understood to ensure that accurate structural information is obtained. In
this case, CD spectroscopy or bioactivity assays are checks on the integrity of protein structure
when employing a new footprinting reagent.
It should be noted that our ability to install synthetically modifications on protein is essentially
limited by the chemistry that is available. Protein modification needs to occur under
physiologically relevant conditions (i.e., usually < 37 ⁰C, pH 6–8, in aqueous milieu with mM
buffer and other salts). The successful use of reagents, therefore, depends on their compatibility
with aqueous environments.
Take the irreversible labeling for example. Development of a new reagent that has unbiased
chemical reactivities at all amino acids, among a sea of reactive carboxylic acids, amides, amines,
alcohols and thiols, is a significant but exciting challenge. Although reactive chemical species (e.g.,
•OH, •CF3, and carbene) theoretically label all amino acids, the rate constants for reaction with the
various amino acid residues are not identical. Thus, no single reactive species will be a panacea
for the wide variety of protein footprinting requirements, necessitating development of other
reactive species.
Last but not least, our understanding of the underlying chemistry in most cases is still incomplete,
and this lack of understanding may give ambiguous structural information. For example, the
modification extent is not only determined by a reagent’s intrinsic chemical reactivities but also
by the microenvironment in protein structure. This fact complicates attempts to find correlations
between reactivity and higher order structure.
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7.3. Future perspective
Several opportunities exist for the future application and development of protein footprinting.
Integrating the range of data obtained by MS into a structural model can be complex, especially
for dynamic systems, wherein model building guided by computer simulations is an essential next
component in the MS toolkit. Nevertheless, advances in these areas have been occurring in recent
years, in parallel by advances in computational platform design. Protein footprinting has been
successfully used to confirm or rule out proposed structural models[1-3], to model interaction,[4] to
facilitate homology modeling,[5] and to correlate oxidative labeling levels with SASA.[6] Further,
the integration of MS data with those from other structural methods, including Cryo-EM and NMR,
presents an opportunity to study increasingly complex systems using an integrative structural
biology approach.
In contrast to soluble proteins, membrane proteins are inherently more difficult to study. Protein
footprinting bodes well for IMP structural analysis because it can probe protein structure and
dynamics with small amount of sample and in a relatively fast fashion. The application and
challenges for IMP footprinting have been discussed previously in Chapters IV and V.
A goal of footprinting is to examine protein structure inside living cells. Although this is difficult
for reversible labeling reagents (e.g., D2O), it is a realistic prospect for irreversible labeling. Li and
coworkers [7] developed isotope encoded NEM to footprint VKOR membrane protein in cell. Jones
and co-workers[8] recently performed in-cell FPOP of live Vero cells. Beyond protein footprinting,
radiolytic footprinting was used to monitor ribosome assembly in bacteria through monitoring of
RNA-based protection as a function of assembly, providing novel and powerful readouts of
complex cellular structures.[9-11]
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Efforts in these directions may evoke a paradigm for protein footprinting in structural proteomics.
MS will remain an integral component of the structural biology toolkit, a toolkit that is sure to
reveal the secrets of how proteins perform the vast functions and interactions essential for life.
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